ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Headache,Headaches NEC,Headaches,Nerv,N
2,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
3,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
4,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
4,2,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
5,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
6,1,Dissociation,Dissociative states,Dissociative disorders,Psych,N
6,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
7,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
8,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
8,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
9,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,2,Hyperadrenocorticism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
9,3,Therapeutic response increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
11,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
12,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
12,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
12,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
13,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
13,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
14,1,Small intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
15,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
15,2,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
16,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
16,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
17,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
17,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
17,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
18,2,Headache,Headaches NEC,Headaches,Nerv,N
18,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
19,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
20,1,Superior vena cava occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
21,1,Superior vena cava occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
22,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
22,2,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
22,3,Superior vena cava occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
23,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
23,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
23,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
23,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
24,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
25,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
26,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
27,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
28,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
28,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
28,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
28,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
30,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
31,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
31,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
32,1,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
32,2,Polymyositis,Muscle infections and inflammations,Muscle disorders,Musc,N
33,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
34,1,Priapism,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
35,1,Cardiac hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
36,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
36,2,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
37,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
37,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
38,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
39,1,Small intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
40,1,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
40,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
41,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
42,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
43,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
44,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
45,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
46,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
46,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
46,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
47,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
48,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
49,1,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
49,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
49,3,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
49,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
49,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
50,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
51,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
51,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
52,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
53,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
53,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
54,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
55,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
56,1,Croup infectious,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
57,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
58,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
59,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
59,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
60,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
61,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
61,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
61,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
62,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
62,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
63,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
63,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
63,3,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
64,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
65,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
66,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
68,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
69,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
69,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
70,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
71,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
72,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
72,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
73,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
74,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
75,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
76,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
76,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
77,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
77,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
78,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
79,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
79,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
80,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
80,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
81,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
81,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
82,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
83,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
83,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
83,3,Increased bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
84,1,Acne,Acnes,Skin appendage conditions,Skin,N
85,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
86,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
87,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
87,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
88,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
89,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
90,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
90,2,Polyarthritis,Arthropathies NEC,Joint disorders,Musc,N
91,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
91,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
91,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
91,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
91,5,Sputum abnormal,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
91,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,1,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
93,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
93,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
94,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
95,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
96,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
97,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
97,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
97,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
98,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
98,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
100,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
101,1,Gastric ulcer perforation,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
102,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
103,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
104,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
105,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
105,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
105,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
105,4,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
106,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
106,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
107,1,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
107,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
108,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
108,2,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
110,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
111,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
111,3,Myopathy,Myopathies,Muscle disorders,Musc,N
112,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
113,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
113,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
113,3,Myopathy,Myopathies,Muscle disorders,Musc,N
114,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
115,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
115,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
115,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
115,4,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
115,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
115,6,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
115,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
115,8,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
116,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
116,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
116,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
116,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
117,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
118,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
119,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
120,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
121,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
122,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
123,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
123,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
124,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
124,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
124,3,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
125,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
125,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
126,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
126,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
126,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
126,4,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
127,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
127,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
127,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
127,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
127,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
127,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
128,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
129,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
130,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
130,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
130,3,Myopathy,Myopathies,Muscle disorders,Musc,N
130,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
131,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
131,2,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
132,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
132,2,Headache,Headaches NEC,Headaches,Nerv,N
132,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
133,1,Coeliac disease,Malabsorption syndromes,Malabsorption conditions,Gastr,N
133,2,Dermatitis herpetiformis,Bullous conditions,Epidermal and dermal conditions,Skin,N
133,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
133,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
133,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
134,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
135,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
136,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
136,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
136,3,Headache,Headaches NEC,Headaches,Nerv,N
137,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
138,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
139,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
139,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
139,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
140,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
140,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
141,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
142,1,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
143,1,Microcytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
143,2,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
144,1,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
145,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
146,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
147,1,Gastroduodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
147,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
148,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
148,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
148,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
149,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
150,1,Perineal pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
151,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
151,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
151,3,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
151,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
151,5,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
151,6,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
152,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
153,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
153,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
154,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
155,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
155,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
156,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
156,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
157,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
157,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
158,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
159,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
159,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
160,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
160,3,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
161,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
162,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
162,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
163,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
164,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
165,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
165,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
166,1,Conjunctivitis allergic,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
167,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
168,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
168,2,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,Y
169,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
169,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
169,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
170,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
171,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
172,1,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
173,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
173,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
173,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
174,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
174,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
174,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
174,4,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
174,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
175,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
175,2,Headache,Headaches NEC,Headaches,Nerv,N
175,3,Hysterical psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
175,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
176,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
176,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
177,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
177,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
178,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
179,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
180,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
181,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
181,2,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
181,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
182,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
182,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
183,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
183,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
184,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
185,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
185,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
185,3,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
186,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
186,2,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
186,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
187,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
187,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
188,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
189,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
189,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
189,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
190,1,Hypoplastic left heart syndrome,Cardiac hypoplasias congenital,Cardiac and vascular disorders congenital,Cong,Y
191,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
191,2,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
192,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
193,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
193,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
193,3,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
193,4,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
193,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
193,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
194,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
194,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
194,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
194,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
194,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,6,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
195,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
195,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
195,3,Deafness,Hearing losses,Hearing disorders,Ear,N
195,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
195,5,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
195,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
195,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
195,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
195,9,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
196,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
196,2,Blood parathyroid hormone increased,Parathyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
196,3,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
197,1,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
198,1,Glioblastoma multiforme,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
199,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
200,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
200,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
200,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
201,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
201,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
201,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
201,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
202,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
202,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
202,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
203,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
203,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
204,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
204,2,Lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
204,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
204,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
205,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
205,2,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
205,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,1,Adrenogenital syndrome,Adrenal disorders congenital,Endocrine disorders congenital,Cong,N
207,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
208,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
209,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,N
210,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
210,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
210,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
210,4,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
210,5,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
210,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
210,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
210,8,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
211,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
211,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
212,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
212,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
213,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
214,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
215,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,Y
216,1,Mesothelioma,Mesotheliomas malignant and unspecified,Mesotheliomas,Neopl,Y
217,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
217,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
217,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
218,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
219,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
220,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
221,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
221,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
221,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
221,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
222,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
222,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
222,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
223,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
224,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
225,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
226,1,Gastrointestinal ulcer perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
227,1,Acne infantile,Acnes,Skin appendage conditions,Skin,N
228,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
229,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
230,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
231,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,2,Headache,Headaches NEC,Headaches,Nerv,N
231,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
232,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
232,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
233,1,Deposit eye,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
234,1,Corneal exfoliation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
235,1,Corneal exfoliation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
236,1,Corneal exfoliation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
237,1,Corneal erosion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
238,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
238,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
239,1,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
240,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
240,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
241,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
241,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
241,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
242,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
242,2,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
243,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
243,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
243,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
244,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
244,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
244,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
245,1,Deafness,Hearing losses,Hearing disorders,Ear,N
245,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
246,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
246,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
247,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
247,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
247,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
248,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
249,1,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
250,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
250,2,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
250,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
250,4,Epidermal necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
250,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
250,6,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
250,7,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
250,8,Inflammation,Inflammations,General system disorders NEC,Genrl,N
250,9,Lichen planus,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
250,10,Lymphocytic infiltration,Leukocytoses NEC,White blood cell disorders,Blood,N
250,11,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
250,12,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
250,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
250,14,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
250,15,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
250,16,Skin oedema,Skin vascular conditions NEC,Skin vascular abnormalities,Skin,N
250,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
250,18,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
251,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
251,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
251,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
251,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
252,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
252,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
252,3,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
253,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
253,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
255,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
255,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
255,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
255,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
255,5,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
255,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
255,8,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
255,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
256,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
256,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
256,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
257,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
258,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
258,2,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
259,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
259,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
259,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
260,1,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
261,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
261,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
261,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
262,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
262,2,Headache,Headaches NEC,Headaches,Nerv,N
262,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
262,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
262,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
263,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
264,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
264,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
264,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
265,1,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
266,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
267,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
267,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
268,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
268,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
269,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
270,1,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
271,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
272,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
273,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
273,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
273,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
274,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
275,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
276,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
276,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
277,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
278,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
279,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
279,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
279,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
280,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
281,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
282,1,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
282,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
282,3,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
282,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
283,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
283,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
283,3,PO2 decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
283,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
284,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
285,1,Blood culture positive,Microbiology and serology tests NEC,Microbiology and serology investigations,Inv,N
285,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
285,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
285,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
285,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
286,1,Nasal oedema,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
286,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
287,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
287,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
288,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
289,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
289,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
290,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
290,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
290,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
290,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
290,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
291,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
292,1,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
292,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
293,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
293,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
293,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
294,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
294,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
294,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
295,1,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
296,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
296,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
297,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
297,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
297,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
298,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
298,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
298,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
298,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
299,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
299,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
299,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
299,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
299,5,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
299,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
300,1,Brain compression,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
300,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
300,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
300,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
300,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
300,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
301,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
301,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
301,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
302,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
302,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
302,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
303,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
303,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
304,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
304,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
304,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
304,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
305,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
305,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
306,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
306,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
306,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
306,4,Oxygen consumption increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
307,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
308,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
309,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
310,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
311,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
311,2,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
311,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
312,1,Corneal deposits,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
313,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
313,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
313,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
313,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
314,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
315,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
316,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
316,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
317,1,Agitated depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
317,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
317,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
318,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
318,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
318,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
318,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
318,5,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
318,6,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
318,7,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
319,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
320,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
320,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
320,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
320,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
322,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
323,1,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,N
323,2,Congenital herpes simplex infection,Viral infections congenital,Infections and infestations congenital,Cong,N
323,3,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,Y
323,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
324,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
324,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
325,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
325,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
325,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
325,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
325,5,Systemic candida,Candida infections,Fungal infectious disorders,Infec,N
326,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
326,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
327,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
327,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
328,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
328,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
329,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
329,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
330,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
330,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
331,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
331,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
332,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
332,2,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
332,3,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
333,1,Blood immunoglobulin G decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
333,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
334,1,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
334,2,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
335,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
336,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
336,2,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
337,1,Anticonvulsant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
337,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
337,3,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
337,4,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
337,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
337,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
337,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
338,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
339,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
339,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
340,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,2,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
341,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
342,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
342,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
343,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
344,1,Nystagmus,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
345,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
345,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
345,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
345,4,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
345,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
345,6,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
345,7,Mucosal ulceration,Mucosal findings abnormal,General system disorders NEC,Genrl,N
345,8,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
345,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
345,11,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
346,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
347,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
347,2,Granulomatosis with polyangiitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
348,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
348,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
348,3,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
348,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
348,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
348,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
349,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
349,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
350,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
351,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
352,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
353,1,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
353,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
354,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
354,2,Diabetic hyperosmolar coma,Coma states,Neurological disorders NEC,Nerv,N
354,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
355,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
355,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
356,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
358,1,Intraocular pressure decreased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
358,2,Iridotomy,Iris and ciliary body therapeutic procedures,Eye therapeutic procedures,Surg,N
358,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
358,4,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
358,5,Retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
358,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
358,7,Vitrectomy,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
359,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
359,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
359,3,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
359,4,Cardiac failure,Heart failures NEC,Heart failures,Card,N
359,5,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
359,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
359,7,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
359,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
359,9,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
359,10,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
359,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
359,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
359,13,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
359,14,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
359,15,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
359,16,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
359,17,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
360,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
360,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
360,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
360,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
361,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
361,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
361,3,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
362,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
363,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
364,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
364,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
365,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
366,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
367,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
368,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
368,2,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
369,1,Croup infectious,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
369,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
369,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
369,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
370,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
370,2,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,Y
370,3,Citrobacter sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
370,4,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
370,5,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
370,6,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
370,7,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
370,8,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
370,9,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
371,1,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
372,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
372,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
372,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
372,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
372,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
373,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
374,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
374,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
375,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
375,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
375,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
375,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
375,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
375,6,Enterovirus infection,Enteroviral infections NEC,Viral infectious disorders,Infec,N
375,7,Extensor plantar response,Abnormal reflexes,Neurological disorders NEC,Nerv,N
375,8,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
375,9,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
375,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
375,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
376,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
377,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
377,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
377,3,Bedridden,Disability issues,Lifestyle issues,SocCi,N
377,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
377,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
377,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
378,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
379,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
379,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
380,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
381,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
382,1,Large intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
382,2,Necrotising colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
382,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
382,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
382,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
382,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
382,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
383,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
384,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
385,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
385,2,Psychomotor retardation,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
385,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
385,4,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
385,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
386,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
386,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
386,3,Salmonellosis,Salmonella infections,Bacterial infectious disorders,Infec,N
387,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
387,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
388,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
388,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
388,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
388,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
388,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
388,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
388,7,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
388,8,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
388,9,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
388,10,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,Y
388,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
388,12,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
388,13,Metastases to adrenals,Metastases to specified sites,Metastases,Neopl,N
388,14,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
388,15,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
388,16,Tumour haemorrhage,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
389,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
389,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
389,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
389,4,Epiglottic oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
389,5,Laryngitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
389,6,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
389,7,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
389,8,Respiratory moniliasis,Candida infections,Fungal infectious disorders,Infec,N
389,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
389,10,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
389,11,Tracheostomy,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
390,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
391,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
392,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
392,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
392,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
392,4,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
392,5,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
392,6,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
393,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
394,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
394,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
394,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
395,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
395,2,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
395,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
395,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
395,5,Heart block congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
395,6,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
395,7,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
396,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
396,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
396,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
396,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
397,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
397,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
397,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
397,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
398,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
398,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
398,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
398,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
399,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
399,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
400,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
401,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
401,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
402,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
402,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
402,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
402,4,Oedema mouth,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
402,5,Oral mucosa atrophy,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
402,6,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
402,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
403,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
403,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
403,3,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
404,1,Headache,Headaches NEC,Headaches,Nerv,N
404,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
404,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
405,1,Acne,Acnes,Skin appendage conditions,Skin,N
406,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
406,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
406,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
406,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
406,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
407,1,Corneal epithelium defect,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
407,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
407,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
407,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
408,1,Corneal epithelium defect,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
408,2,Corneal striae,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
408,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
408,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
409,1,Corneal epithelium defect,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
409,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
409,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
409,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
410,1,Follicular mucinosis,Alopecias,Skin appendage conditions,Skin,N
410,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
411,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
412,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
413,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
413,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
414,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
415,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
416,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
417,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
417,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
418,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
419,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
420,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
421,1,Dacryocanaliculitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
421,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
421,3,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
421,4,Keratitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
421,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
422,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
422,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
422,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
423,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
423,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
423,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
423,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
423,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
424,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
425,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
426,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
427,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
427,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
428,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
429,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
429,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
429,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
429,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
430,1,Anastomotic leak,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
431,1,Post procedural discharge,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
432,1,Anastomotic leak,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
433,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
433,2,IVth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
433,3,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
434,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
435,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
436,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
437,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
438,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
438,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
438,3,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
438,4,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
438,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
439,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
439,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
439,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
440,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
441,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
441,2,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
442,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
443,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
444,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
444,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
444,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
444,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
445,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
445,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
445,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
446,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
446,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
446,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
446,4,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
446,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
446,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
447,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
448,1,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
449,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
450,1,Large intestine infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
451,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
452,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
452,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
452,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
452,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
452,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
453,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
454,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
454,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
454,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
454,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
454,5,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
454,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
455,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
455,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
456,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
456,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
457,1,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
458,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
459,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
460,1,ACTH stimulation test abnormal,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
460,2,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
460,3,Blood corticotrophin decreased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
460,4,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
460,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
460,6,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
460,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
461,1,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
461,2,Sudden visual loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
462,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
463,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
464,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
465,1,Corneal decompensation,Corneal disorders NEC,Eye disorders NEC,Eye,N
465,2,Device dislocation,Device issues NEC,Device issues,Prod,N
466,1,Corneal decompensation,Corneal disorders NEC,Eye disorders NEC,Eye,N
467,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
468,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
469,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
469,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
470,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
470,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
470,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
470,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
470,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
470,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
470,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
470,8,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
470,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
471,1,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
471,2,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
471,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
472,1,Abdominal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
472,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
472,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
472,4,Pancreatic carcinoma stage IV,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
472,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
473,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
473,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
474,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
475,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
475,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
475,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
475,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
475,5,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
475,6,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
475,7,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
476,1,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
476,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
477,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
478,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
479,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
479,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
480,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
480,2,DiGeorge's syndrome,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
480,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
481,1,Clostridial sepsis,Clostridia infections,Bacterial infectious disorders,Infec,Y
481,2,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
482,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
482,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
482,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
483,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
484,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
485,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
485,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
485,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
485,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
485,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
485,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
485,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
485,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
486,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
486,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
487,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
488,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
488,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
488,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
488,4,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
488,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
489,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
490,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
491,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
492,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
493,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
494,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
494,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
495,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
495,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
496,1,Febrile infection,Infections NEC,Infections - pathogen unspecified,Infec,N
496,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
496,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
497,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
497,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
498,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
498,2,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
498,3,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
499,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
500,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
500,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
501,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
501,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
502,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
502,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
502,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
502,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
503,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
503,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
503,3,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
504,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
504,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
505,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
505,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
505,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
505,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
505,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
505,6,Respiratory depth decreased,Breathing abnormalities,Respiratory disorders NEC,Resp,N
506,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
506,2,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
506,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
507,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
508,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
508,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
509,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
510,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
510,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
510,3,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
510,4,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
510,5,Bursitis,Bursal disorders,Synovial and bursal disorders,Musc,N
510,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
510,7,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
510,8,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
510,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
510,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
510,11,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
510,12,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
510,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
510,14,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
510,15,Gastrointestinal toxicity,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
510,16,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
510,17,Headache,Headaches NEC,Headaches,Nerv,N
510,18,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
510,19,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
510,20,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
510,21,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
510,22,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
510,23,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
510,24,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
510,25,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
510,26,Myopathy,Myopathies,Muscle disorders,Musc,N
510,27,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
510,28,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
510,29,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
510,30,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
510,31,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
510,32,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
510,33,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
510,34,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
510,35,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
510,36,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
510,37,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
510,38,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
511,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
511,3,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
511,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
511,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
511,6,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
511,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
511,8,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
511,9,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
511,11,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
511,12,Headache,Headaches NEC,Headaches,Nerv,N
511,13,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
511,14,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
511,15,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
511,16,Nail infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
511,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
511,18,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
511,19,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
511,20,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
511,21,Sterile pyuria,Genitourinary tract infections and inflammations NEC,Genitourinary tract disorders NEC,Renal,N
511,22,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
511,23,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
511,24,Urinary tract disorder,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
511,25,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
512,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
512,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
512,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
513,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
514,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
514,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
515,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
515,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
516,1,Device dislocation,Device issues NEC,Device issues,Prod,N
517,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
517,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
517,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
517,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
517,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
518,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
519,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
519,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
519,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
519,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
520,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
520,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
521,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
521,2,Myopathy,Myopathies,Muscle disorders,Musc,N
522,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
522,2,Corneal thickening,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
522,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
522,4,Iritis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
522,5,Keratic precipitates,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
522,6,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
523,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
523,2,Lenticular opacities,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
523,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
524,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
524,2,Myopathy,Myopathies,Muscle disorders,Musc,N
525,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
526,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
527,1,Corneal decompensation,Corneal disorders NEC,Eye disorders NEC,Eye,N
527,2,Corneal thickening,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
527,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
527,4,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
527,5,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
528,1,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
528,2,Flat anterior chamber of eye,"Anterior chamber structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
528,3,Headache,Headaches NEC,Headaches,Nerv,N
528,4,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
528,5,Lens extraction,Lens therapeutic procedures,Eye therapeutic procedures,Surg,N
529,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
529,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
529,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
530,1,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
531,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
532,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
532,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
532,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
533,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
534,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
535,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
535,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
535,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
535,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
535,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
535,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
535,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
535,8,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
535,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
535,10,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
536,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
536,2,Jarisch-Herxheimer reaction,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
536,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
537,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
537,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
537,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
537,4,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
538,1,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
539,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
539,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
539,3,Otitis media chronic,Ear infections,Infections - pathogen unspecified,Infec,N
540,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
540,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
540,3,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
540,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
540,5,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
540,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
541,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
541,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
541,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
542,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
543,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
544,1,Deafness,Hearing losses,Hearing disorders,Ear,N
545,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
545,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
545,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
545,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
545,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
545,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
545,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
545,8,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
545,9,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
545,10,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
545,11,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
545,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
546,1,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
547,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
547,2,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
548,1,Cerebral ischaemia,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
549,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
550,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
550,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
551,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
551,2,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
551,3,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
552,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
552,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
552,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
553,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
553,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
553,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
553,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
554,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
555,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
555,2,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
556,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
556,2,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
556,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
556,4,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
557,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
558,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
558,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
558,3,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
558,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
558,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
559,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
560,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
561,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
562,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
562,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
562,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
563,1,Deafness,Hearing losses,Hearing disorders,Ear,N
563,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
564,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
564,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
565,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
565,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
566,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
567,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
567,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
568,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
568,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
568,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
569,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
569,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
570,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
571,1,Oesophageal haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
572,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
572,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
573,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
573,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
574,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
575,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
576,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
576,2,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
577,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
577,2,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
578,1,Keratitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
579,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
580,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
581,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
581,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
582,1,Implantation complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
582,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
582,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
583,1,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
583,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
583,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
584,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
584,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
585,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
585,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
585,3,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
586,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
586,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
587,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
588,1,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
589,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
589,2,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
589,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
589,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
589,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
589,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
589,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
589,8,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
589,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
589,10,Vascular access complication,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
589,11,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
590,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
591,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
592,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
593,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
593,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
593,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
593,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
593,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
593,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
593,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
593,8,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
593,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
593,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
593,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
593,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
594,1,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
595,1,Anterior chamber cell,Chambers (anterior and posterior) and lens infections and inflammations,"Ocular infections, irritations and inflammations",Eye,N
595,2,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
595,3,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
595,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
595,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
595,6,Toxic anterior segment syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
595,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
596,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
597,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
597,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
597,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
598,1,Anticoagulation drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
598,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
598,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
598,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
599,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
600,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
601,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
601,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
601,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
601,4,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
601,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
602,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
602,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
602,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
602,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
602,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
602,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
602,7,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
602,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
603,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
603,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
604,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
604,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
605,1,Neovascularisation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
605,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
606,1,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
607,1,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
607,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
607,3,Vitreous opacities,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
608,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
609,1,Procedural hypotension,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
610,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
610,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
611,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
611,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
612,1,Sudden visual loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
613,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
613,2,Hemianopia homonymous,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
613,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
613,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
614,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
615,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
616,1,Corneal erosion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
617,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
617,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
617,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
618,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
619,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
620,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,Y
621,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
621,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
621,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
621,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
622,1,Glucose tolerance test abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
622,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
622,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
623,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
623,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
623,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
623,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
624,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
624,2,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
624,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
625,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
626,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
626,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
627,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
627,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
628,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
629,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
629,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
630,1,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
630,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
631,1,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
631,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
632,1,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
632,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
633,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,Y
634,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
634,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
634,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
634,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
634,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
634,6,Vocal cord paralysis,Vagus nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
634,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
635,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
635,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
636,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
636,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
636,3,Headache,Headaches NEC,Headaches,Nerv,N
636,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
637,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
637,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
637,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
638,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
638,2,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
638,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
638,4,Delirium,Deliria,Deliria (incl confusion),Psych,N
638,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
638,6,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
638,7,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
638,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
638,9,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
638,10,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
638,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
639,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
639,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
640,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
640,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
640,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
640,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
641,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
641,2,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
641,3,Detached Descemet's membrane,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
641,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
642,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
643,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
644,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
644,2,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
644,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
644,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
645,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
646,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
646,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
647,1,Giant papillary conjunctivitis,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
647,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
647,3,Reaction to preservatives,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
648,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
649,1,Infective exacerbation of bronchiectasis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
649,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
650,1,Deafness,Hearing losses,Hearing disorders,Ear,N
650,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
651,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
651,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
652,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
653,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
654,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
655,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
656,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
656,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
656,3,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
656,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
656,5,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
657,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
657,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
657,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
657,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
657,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
657,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
658,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
659,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
660,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
660,2,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
661,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
661,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
661,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
661,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
662,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
662,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
662,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
662,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
663,1,Complication associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
663,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
664,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
664,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
664,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
664,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
665,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
665,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
666,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
666,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
666,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
667,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
667,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
668,1,Cataract operation,Lens therapeutic procedures,Eye therapeutic procedures,Surg,N
668,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
669,1,Corneal decompensation,Corneal disorders NEC,Eye disorders NEC,Eye,N
669,2,Device dislocation,Device issues NEC,Device issues,Prod,N
670,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
671,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
672,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
673,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
673,2,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
674,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
675,1,Abulia,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
675,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
675,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
675,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
675,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
675,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
676,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
676,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
676,3,Optic disc disorder,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
677,1,Cervical spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
677,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
678,1,Bacteriuria,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
678,2,Pneumonia necrotising,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
678,3,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
679,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
679,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
679,3,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
680,1,Ammonia increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
680,2,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
680,3,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
680,4,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
680,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
680,6,Hyperammonaemic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
680,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
680,8,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
680,9,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
680,10,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
680,11,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
680,12,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
680,13,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
681,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
682,1,Abdominal wound dehiscence,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
683,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
683,2,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
683,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
683,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
683,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
683,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
683,7,Pseudophaeochromocytoma,Adrenal medulla disorders,Adrenal gland disorders,Endo,N
683,8,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
684,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
684,2,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
685,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
685,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
685,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
686,1,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
687,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
688,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
688,2,Contraindication to medical treatment,Social issues NEC,Lifestyle issues,SocCi,N
688,3,Deafness,Hearing losses,Hearing disorders,Ear,N
688,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
688,5,Headache,Headaches NEC,Headaches,Nerv,N
688,6,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
688,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
689,1,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
690,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
690,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
691,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
692,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
692,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
692,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
692,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
692,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
692,6,Temperature difference of extremities,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
693,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
693,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
693,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
693,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
693,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
693,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
693,7,Procedural intestinal perforation,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
693,8,Varices oesophageal,Oesophageal varices,Gastrointestinal vascular conditions,Gastr,N
694,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
694,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
694,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
694,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
695,1,Ocular vascular disorder,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
695,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
695,3,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
696,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
696,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
697,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
697,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
697,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
698,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
698,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
699,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
699,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
699,3,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
699,4,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
699,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
699,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
699,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
699,8,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
699,9,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
700,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
700,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
701,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
702,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
703,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
703,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
704,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
705,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
705,2,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
705,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
705,4,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
706,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
707,1,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
707,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
708,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
709,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
709,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
709,3,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
709,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
709,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
709,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
709,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
709,8,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
709,9,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
710,1,Duodenal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
710,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
711,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
712,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
713,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
713,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
713,3,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
713,4,Reaction to preservatives,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
713,5,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
714,1,Duodenal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
714,2,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
715,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
715,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
715,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
715,4,Defaecation urgency,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
715,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
715,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
715,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
715,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
715,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
716,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
716,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
716,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
717,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
718,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
718,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
718,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
718,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
719,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
719,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
720,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
720,2,Epidural lipomatosis,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
720,3,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
721,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
721,2,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
722,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
722,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
723,1,Foreign body in eye,Eye injuries NEC,Injuries NEC,Inj&P,N
724,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
724,2,Respiratory syncytial virus bronchiolitis,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
725,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
725,2,Ocular vascular disorder,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
725,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
725,4,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
725,5,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
726,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
726,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
726,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
726,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
726,5,Osmotic demyelination syndrome,Demyelinating disorders NEC,Demyelinating disorders,Nerv,Y
727,1,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
728,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
728,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
729,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
729,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
729,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
730,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
730,2,Pathological fracture,Fractures NEC,Fractures,Musc,N
731,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
731,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
731,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
731,4,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
731,5,Headache,Headaches NEC,Headaches,Nerv,N
731,6,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
731,7,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
731,8,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
731,9,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
731,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
731,11,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
731,12,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
731,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
731,14,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
731,15,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
731,16,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
732,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
733,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
733,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
733,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
734,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
735,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
735,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
735,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
735,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
736,1,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
737,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
737,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
737,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
737,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
738,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
738,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
739,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
739,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
740,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
741,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
741,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
741,3,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
741,4,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
741,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
741,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
741,7,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
741,8,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
741,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
741,10,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
741,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
741,12,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
741,13,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
741,14,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
741,15,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
741,16,Respiratory gas exchange disorder,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
741,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
741,18,Sputum retention,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
742,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
742,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
742,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
742,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
742,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
742,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
742,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
742,8,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
742,9,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
742,10,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
742,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
742,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
743,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
743,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
743,3,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
743,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
743,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
743,6,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
744,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
744,2,Disability,Disability issues,Lifestyle issues,SocCi,N
744,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
744,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
744,5,Recurrent cancer,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
744,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
744,7,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
745,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
745,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
746,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
747,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
748,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
749,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
749,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
749,3,Thermal burns of eye,Thermal burns,Injuries by physical agents,Inj&P,N
749,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
750,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
750,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
751,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
752,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
753,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
754,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
754,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
755,1,Metastases to skin,Metastases to specified sites,Metastases,Neopl,Y
756,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
757,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
757,2,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
757,3,Foreign body in eye,Eye injuries NEC,Injuries NEC,Inj&P,N
757,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
757,5,Posterior capsule rupture,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
758,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
758,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
758,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
759,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
760,1,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
761,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
761,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
761,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
761,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
761,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
761,6,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
761,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
761,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
761,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
761,10,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
761,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
761,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
762,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
762,2,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
763,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
763,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
764,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
765,1,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,Y
766,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
767,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
767,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
767,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
767,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
767,5,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
768,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
768,2,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
769,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
769,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
770,1,Apnoeic attack,Breathing abnormalities,Respiratory disorders NEC,Resp,N
770,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
770,3,Decerebrate posture,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
771,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
771,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
772,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
773,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
774,1,Myopathy,Myopathies,Muscle disorders,Musc,N
775,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
775,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
775,3,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
776,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
776,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
777,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
778,1,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
778,2,Myopathy,Myopathies,Muscle disorders,Musc,N
778,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
778,4,Visceral leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
778,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
779,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
779,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
780,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
780,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
780,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
780,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
780,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
780,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
780,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
780,8,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
780,9,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
780,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
781,1,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
781,2,Prostate cancer metastatic,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
782,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
782,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
782,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
783,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
783,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
783,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
783,4,Hepatic mass,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
783,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
783,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
783,7,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
783,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
783,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
784,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
785,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
785,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
785,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
785,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
786,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
786,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
787,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
787,2,Gravitational oedema,Oedema NEC,General system disorders NEC,Genrl,N
787,3,Headache,Headaches NEC,Headaches,Nerv,N
787,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
788,1,Duodenal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
788,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
789,1,Device dislocation,Device issues NEC,Device issues,Prod,N
790,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
791,1,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
792,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
793,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
794,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
794,2,Myopathy,Myopathies,Muscle disorders,Musc,N
794,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
794,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
795,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
795,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
795,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
795,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
796,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
797,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
798,1,Implantation complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
799,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
799,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
799,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
799,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
800,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
801,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
802,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,Y
803,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
804,1,Deafness,Hearing losses,Hearing disorders,Ear,N
804,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
804,3,Headache,Headaches NEC,Headaches,Nerv,N
804,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
805,1,Differentiation syndrome,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
805,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
805,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
805,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
805,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
805,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
806,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
806,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
806,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
806,4,Hyperosmolar state,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
806,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
807,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
807,2,Faecal vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
807,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
808,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
808,2,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
808,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
808,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
808,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
808,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
808,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
808,8,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
808,9,Violence-related symptom,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
809,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
809,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
809,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
809,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
810,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
810,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
810,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
810,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
810,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
811,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
812,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
812,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
812,3,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
813,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
813,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
813,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
813,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
813,5,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
813,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
814,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
815,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
815,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
815,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
816,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
816,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
817,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
818,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
819,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
819,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
819,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
820,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
820,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
820,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
821,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
821,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
822,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
822,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
823,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
823,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
823,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
823,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
823,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
823,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
823,7,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
823,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
823,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
823,10,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
823,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
824,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
825,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
825,2,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
825,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
826,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
826,2,Visual brightness,Visual disorders NEC,Vision disorders,Eye,N
827,1,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
828,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
828,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
828,3,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
828,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
829,1,Epidural lipomatosis,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
829,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
830,1,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
830,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
831,1,Epidural lipomatosis,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
831,2,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
832,1,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
832,2,Agranulocytosis,Neutropenias,White blood cell disorders,Blood,N
832,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
832,4,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
832,5,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
832,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
832,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
832,8,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
832,9,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
832,10,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
832,11,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
832,12,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
832,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
832,14,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
832,15,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
833,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
833,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
833,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
833,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
833,5,Pulmonary toxicity,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
834,1,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
835,1,Deafness,Hearing losses,Hearing disorders,Ear,N
835,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
835,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
835,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
836,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
837,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
837,2,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
837,3,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
837,4,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
837,5,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
837,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
838,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
839,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
840,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
840,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
840,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
841,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
842,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
842,2,Candidiasis of trachea,Candida infections,Fungal infectious disorders,Infec,N
842,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
842,4,Epiglottic oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
842,5,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
842,6,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
842,7,Respiratory moniliasis,Candida infections,Fungal infectious disorders,Infec,N
842,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
842,9,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
842,10,Tracheostomy,Tracheal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
843,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
843,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
843,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
844,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
844,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
844,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
844,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
845,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
845,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
845,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
846,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
846,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
847,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
847,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
848,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
848,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
849,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
849,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
849,3,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
850,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
850,2,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
851,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
851,2,Headache,Headaches NEC,Headaches,Nerv,N
851,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
852,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
853,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
853,2,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
854,1,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
855,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
855,2,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
855,3,Corneal thickening,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
855,4,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
855,5,Keratic precipitates,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
855,6,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
855,7,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
855,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
855,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
856,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
856,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
856,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
856,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
856,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
856,6,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
857,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
857,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
858,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
858,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
859,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
860,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
860,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
860,3,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
860,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
860,5,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
861,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
862,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
863,1,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
864,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
864,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
865,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
865,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
866,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
867,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
867,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
867,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
867,4,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
867,5,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
867,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
867,7,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
867,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
867,9,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
867,10,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
868,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
868,2,Headache,Headaches NEC,Headaches,Nerv,N
868,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
868,4,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
869,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
870,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
870,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
870,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
870,4,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
871,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
871,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
872,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
872,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
873,1,Deafness,Hearing losses,Hearing disorders,Ear,N
873,2,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
874,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
874,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
875,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
875,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
875,3,Headache,Headaches NEC,Headaches,Nerv,N
875,4,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
875,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
875,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
875,7,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
875,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
876,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
877,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
877,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
877,3,Focal dyscognitive seizures,Partial complex seizures,Seizures (incl subtypes),Nerv,N
877,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
877,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
878,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
879,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
880,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
880,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
881,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
882,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
882,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
883,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
883,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
884,1,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
885,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
886,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
886,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
886,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
887,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
887,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
887,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
887,4,Migraine,Migraine headaches,Headaches,Nerv,N
888,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
888,2,Anticoagulation drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
888,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
889,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
889,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
889,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
889,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
889,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
889,6,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
889,7,Illogical thinking,Thinking disturbances,Disturbances in thinking and perception,Psych,N
889,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
889,9,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
889,10,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
889,11,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
890,1,Monoparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
890,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
890,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
891,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
891,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
892,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
893,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
894,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
894,2,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
894,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
894,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
895,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
895,2,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
895,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
895,4,Gross motor delay,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
895,5,Plagiocephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
895,6,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
895,7,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
896,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
896,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
896,3,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
897,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
897,2,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
897,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
898,1,Retinal tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
899,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
899,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
900,1,Exposed bone in jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
900,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
901,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
902,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
903,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
903,2,Hemianopia,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
904,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
904,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
905,1,Influenza A virus test,Virus identification and serology,Microbiology and serology investigations,Inv,N
905,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
906,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
906,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
906,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
906,4,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
907,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
907,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
908,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
908,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
909,1,Blood chloride decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
909,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
909,3,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
909,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
909,5,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
909,6,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
909,7,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
909,8,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
909,9,Keratopathy,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
909,10,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
910,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
910,2,Corneal dystrophy,Corneal and scleral disorders congenital,Eye disorders congenital,Cong,N
910,3,Corneal scar,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
910,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
910,5,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
911,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
911,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
911,3,Electrocardiogram Q waves,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
911,4,Hyperdynamic left ventricle,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
911,5,Hypertensive heart disease,Cardiac hypertensive complications,"Cardiac disorders, signs and symptoms NEC",Card,N
911,6,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
911,7,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
911,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
911,9,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
911,10,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
911,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
911,12,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
911,13,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
911,14,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
911,15,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
912,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
912,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
913,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
913,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
913,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
913,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
913,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
913,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
914,1,Anorectal disorder,Anal and rectal disorders NEC,Anal and rectal conditions NEC,Gastr,N
914,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
914,3,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
915,1,Postmenopausal haemorrhage,Menopausal effects on the genitourinary tract,Menopause related conditions,Repro,N
916,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
916,2,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
916,3,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
916,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
916,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
916,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
916,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
916,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
917,1,Excessive cerumen production,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
917,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
918,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
918,2,Corneal dystrophy,Corneal and scleral disorders congenital,Eye disorders congenital,Cong,N
918,3,Corneal thinning,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
918,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
918,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
918,6,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
918,7,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
918,8,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
918,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
919,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
919,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
920,1,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
920,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
921,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
921,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
921,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
921,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
921,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
921,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
921,7,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
921,8,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
921,9,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
921,10,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
922,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
922,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
922,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
922,4,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
922,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
922,6,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
922,7,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
922,8,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
922,9,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
922,10,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
922,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
922,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
922,13,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
922,14,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
922,15,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
922,16,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
922,17,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
922,18,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
923,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
923,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
924,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
925,1,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
925,2,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
926,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
927,1,Device dislocation,Device issues NEC,Device issues,Prod,N
927,2,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
928,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
928,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
928,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
929,1,Headache,Headaches NEC,Headaches,Nerv,N
930,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
931,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
932,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
933,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
934,1,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
934,2,Corneal thinning,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
934,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
934,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
934,5,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
934,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
935,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
935,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
935,3,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
935,4,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
935,5,Retinal pigment epitheliopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
936,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
936,2,Corneal dystrophy,Corneal and scleral disorders congenital,Eye disorders congenital,Cong,N
936,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
936,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
936,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
936,6,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
937,1,Corneal abrasion,Eye injuries NEC,Injuries NEC,Inj&P,N
937,2,Corneal scar,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
937,3,Corneal thinning,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
937,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
937,5,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
937,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
937,7,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
937,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
938,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
938,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
938,3,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
938,4,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
939,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
939,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
939,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
939,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
939,5,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
939,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
939,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
940,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
940,2,Retinal pigment epitheliopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
941,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
941,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
941,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
941,4,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
942,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
942,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
942,3,Keratopathy,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
942,4,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
943,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
943,2,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
943,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
943,4,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
944,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
944,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
944,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
944,4,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
945,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
946,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
946,2,Non-small cell lung cancer,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
947,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
947,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
948,1,Adrenal suppression,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
948,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
948,3,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
949,1,Cellulitis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
949,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
949,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
949,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
949,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
949,6,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
949,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
949,8,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
949,9,Proteus infection,Proteus infections,Bacterial infectious disorders,Infec,N
949,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
949,11,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
949,12,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
949,13,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
950,1,Escherichia bacteraemia,Escherichia infections,Bacterial infectious disorders,Infec,N
951,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
951,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
951,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
951,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
951,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
951,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
951,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
951,8,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
951,9,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
952,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
952,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
953,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
953,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
953,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
953,4,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
953,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
953,6,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
953,7,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
953,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
954,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
954,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
955,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
956,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
956,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
956,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
956,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
956,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
957,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
957,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
957,3,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
957,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
958,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
958,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
958,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
958,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
958,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
959,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
960,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
960,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
960,3,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
960,4,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
960,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
960,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
960,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
960,8,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
960,9,Pulpitis dental,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
960,10,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
961,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
962,1,Central obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
962,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
962,3,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
962,4,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
962,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
963,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
963,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
964,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
965,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
965,2,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
965,3,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
965,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
965,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
965,6,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
965,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
965,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
965,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
965,10,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
965,11,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
965,12,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
965,13,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
965,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
965,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
965,16,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
965,17,Stoma site pain,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
966,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
966,2,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
967,1,Headache,Headaches NEC,Headaches,Nerv,N
968,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
968,2,Product monitoring error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
968,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
969,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
969,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
969,3,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
969,4,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
969,5,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
969,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
969,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
969,8,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
969,9,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
969,10,Pulpitis dental,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
969,11,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
969,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
970,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
970,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
970,3,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
970,4,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
970,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
971,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
971,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
971,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
971,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
971,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
972,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
973,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
974,1,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
975,1,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
976,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
976,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
976,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
976,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
976,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
976,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
976,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
976,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
976,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
976,10,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
976,11,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
977,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
978,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
978,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
978,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
979,1,Trabeculectomy,Iris and ciliary body therapeutic procedures,Eye therapeutic procedures,Surg,N
980,1,Salivary duct obstruction,Salivary gland stenosis and obstruction,Salivary gland conditions,Gastr,N
980,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
981,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
982,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
983,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
984,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
984,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
985,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
986,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
987,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
988,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
988,2,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
988,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
988,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
988,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
988,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
988,7,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
988,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
988,9,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
988,10,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
988,11,Headache,Headaches NEC,Headaches,Nerv,N
988,12,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
988,13,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
988,14,Intercepted product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
988,15,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
988,16,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
988,17,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
988,18,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
988,19,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
988,20,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
988,21,Pharyngeal erythema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
988,22,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
988,23,Sputum discoloured,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
988,24,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
989,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
989,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
989,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
990,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
990,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
990,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
990,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
991,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
991,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
991,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
991,4,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
991,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
991,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
991,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
991,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
992,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
992,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
992,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
992,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
993,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
993,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
993,3,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
994,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
995,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
995,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
995,3,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
995,4,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
995,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
995,6,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
995,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
995,8,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
995,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
995,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
995,11,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
995,12,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
995,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
995,14,Headache,Headaches NEC,Headaches,Nerv,N
995,15,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
995,16,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
995,17,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
995,18,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
995,19,Myalgia,Muscle pains,Muscle disorders,Musc,N
995,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
995,21,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
995,22,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
995,23,Respiratory tract infection viral,Viral infections NEC,Viral infectious disorders,Infec,N
995,24,Synovial cyst,Synovial disorders,Synovial and bursal disorders,Musc,N
995,25,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
995,26,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
995,27,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
995,28,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
996,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
996,2,Headache,Headaches NEC,Headaches,Nerv,N
997,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
997,2,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
998,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
999,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
999,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
999,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
999,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
999,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
999,6,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
999,7,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
999,8,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
999,9,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
999,10,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
999,11,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
999,12,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
999,13,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
999,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
999,15,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
999,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
999,17,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
999,18,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1000,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
1000,2,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
1000,3,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1000,4,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1001,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1001,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1001,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1002,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
1002,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1003,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1004,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1004,2,Keratopathy,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1004,3,Punctate keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1004,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1005,1,Periprosthetic fracture,Musculoskeletal procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1006,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1006,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1007,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1007,2,Disorder of globe,Ocular disorders NEC,Eye disorders NEC,Eye,N
1007,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1007,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1007,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1007,6,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1008,1,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
1008,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1009,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1010,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1011,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
1011,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1011,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1011,4,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1011,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1012,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1013,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1014,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1014,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1014,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1015,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1015,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1015,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1016,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1016,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1016,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1016,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1016,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1017,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1017,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1017,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1017,4,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1017,5,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1017,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1017,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1017,8,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1017,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1018,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1018,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1019,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1019,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1019,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1019,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1020,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1020,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1020,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1020,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1020,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1021,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1021,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1021,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1021,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1021,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1021,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1021,7,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1021,8,External ear cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1021,9,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1021,10,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1021,11,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1021,12,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1021,13,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1022,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1023,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1023,2,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1023,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1023,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1023,5,Appendicitis perforated,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1023,6,Diverticulum intestinal haemorrhagic,Diverticula,Diverticular disorders,Gastr,N
1023,7,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1023,8,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1023,9,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1023,10,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1024,1,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1024,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1025,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1025,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1025,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1025,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1025,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1025,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1026,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1026,2,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1026,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1027,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1027,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1028,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1029,1,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
1029,2,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1029,3,Detached Descemet's membrane,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1029,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1029,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1030,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1031,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1031,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1031,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1031,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1032,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1032,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1032,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1032,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1032,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1032,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1033,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1033,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1033,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1033,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1033,5,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1033,6,Tension headache,Headaches NEC,Headaches,Nerv,N
1034,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1034,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1035,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1036,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1036,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1036,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1036,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1036,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1037,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1037,2,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1037,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1038,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1039,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1039,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1039,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1040,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1040,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1040,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1041,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1041,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1042,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
1042,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1042,3,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1042,4,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1043,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1044,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1044,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1045,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1045,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1045,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1045,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1046,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1046,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1046,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1046,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1047,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1048,1,Device failure,Device issues NEC,Device issues,Prod,N
1048,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1048,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1048,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1049,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1050,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1051,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1051,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1052,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1053,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1054,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1055,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1055,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1055,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1055,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1055,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1056,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1056,2,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1057,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1057,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1058,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1058,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1058,3,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1058,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1058,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1059,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1060,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1060,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1061,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
1061,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1061,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1061,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1061,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1062,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1062,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1062,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1063,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1063,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1064,1,Dark circles under eyes,Ocular disorders NEC,Eye disorders NEC,Eye,N
1064,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1064,3,Yellow skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1065,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1066,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1066,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1066,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1066,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1066,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1066,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1067,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1067,2,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1068,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1068,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1068,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1069,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1069,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1070,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1070,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1070,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1070,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1070,5,Headache,Headaches NEC,Headaches,Nerv,N
1070,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1070,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1070,8,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1071,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1072,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1073,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1074,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1075,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1076,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1077,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1078,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1079,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1079,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1079,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1079,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1079,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1079,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1080,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1080,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1081,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1081,2,Wound sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1082,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1082,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1082,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1082,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1082,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1082,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1082,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1082,8,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1082,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1082,10,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1082,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1082,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1082,13,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1083,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1083,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1084,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1084,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1084,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1084,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1084,5,Monoclonal immunoglobulin present,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1084,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1085,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1085,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1085,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1086,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1086,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1087,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1087,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1087,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1088,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1089,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1089,2,Diverticular perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1089,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1089,4,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1089,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1089,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1090,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1090,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1091,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1091,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1092,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1093,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1093,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1093,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1093,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1094,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1094,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1094,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1094,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1094,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1094,6,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1094,7,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1094,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1094,9,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1094,10,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1095,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1095,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1095,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1096,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1096,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1097,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1098,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1099,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1100,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1100,2,Headache,Headaches NEC,Headaches,Nerv,N
1100,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1101,1,Myelodysplastic syndrome with multilineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,N
1101,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1102,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1102,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1102,3,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1102,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1102,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1102,6,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1102,7,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1103,1,Bundle branch block left,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1103,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1103,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1103,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1103,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1103,6,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1104,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
1105,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1106,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1107,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1107,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1108,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1109,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1109,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1109,3,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1109,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1109,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1110,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1111,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1111,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1111,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1111,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1112,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1113,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1113,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1113,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1113,4,Sternal fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
1114,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1114,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1114,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
1114,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1114,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1114,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1115,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1115,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1116,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1117,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1117,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1117,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1118,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1119,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1119,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1120,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1121,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1122,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1122,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1123,1,Eyelid irritation,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1124,1,Corneal endothelial cell loss,Corneal disorders NEC,Eye disorders NEC,Eye,N
1124,2,Device dislocation,Device issues NEC,Device issues,Prod,N
1124,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1125,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1125,2,Myopathy,Myopathies,Muscle disorders,Musc,N
1126,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1126,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1127,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1128,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1128,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1129,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1129,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1129,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1129,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1129,5,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1129,6,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
1130,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1130,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1131,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1132,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1133,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1134,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1134,2,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
1134,3,Vitreous loss,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1135,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1135,2,Skin fragility,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1136,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1136,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1136,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1137,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1137,2,Hypertensive heart disease,Cardiac hypertensive complications,"Cardiac disorders, signs and symptoms NEC",Card,N
1137,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1137,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1137,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1138,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1138,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1138,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1138,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1138,5,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1138,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1138,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1139,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1140,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1141,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1142,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1142,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1142,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1142,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1143,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1143,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1143,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1144,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1144,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1145,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1146,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1146,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1147,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1147,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1147,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1147,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1147,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1148,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1149,1,Parosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1150,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1150,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1151,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1151,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1152,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1152,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1152,3,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1153,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1153,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1153,3,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1153,4,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1153,5,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
1153,6,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1153,7,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
1153,8,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1153,9,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1153,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1153,11,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1153,12,Gallbladder enlargement,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
1153,13,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1153,14,Murphy's sign positive,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1153,15,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1153,16,Ultrasound abdomen abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
1153,17,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1154,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1154,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1154,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1154,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1154,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1154,6,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1154,7,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1154,8,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1154,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1154,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1154,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1155,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1155,2,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1155,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1156,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1157,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1158,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1159,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1159,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1159,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1159,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1160,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1160,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1160,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1160,4,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1160,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1161,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1161,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1161,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1161,4,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1161,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1161,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1161,7,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1161,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1162,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1162,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1163,1,Blood albumin decreased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1163,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1163,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1163,4,Idiosyncratic drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1164,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1165,1,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1165,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1166,1,Headache,Headaches NEC,Headaches,Nerv,N
1167,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1167,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1167,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1168,1,Cholecystitis acute,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
1168,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1169,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1169,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1169,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1170,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1170,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1170,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1170,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
1170,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1170,6,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
1170,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1170,8,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1171,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1172,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1172,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1172,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1173,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1173,2,Large intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1173,3,Peritoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1174,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1174,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
1174,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1174,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1174,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1174,6,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1174,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1175,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1175,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1175,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1175,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1176,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1176,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,Y
1177,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1177,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1177,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1178,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1179,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1179,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1180,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1180,2,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1180,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1180,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1180,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1180,6,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1181,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1182,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1182,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1183,1,Arteriovenous fistula thrombosis,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1183,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1183,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1184,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1185,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1185,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1185,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1185,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1186,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1186,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1187,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1188,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1189,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
1189,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1190,1,Headache,Headaches NEC,Headaches,Nerv,N
1190,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1191,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1192,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1192,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1192,3,Secondary hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1192,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1193,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1194,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1194,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1194,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1194,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1194,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1194,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1194,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1194,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1194,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1194,10,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1194,11,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1194,12,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1195,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
1195,2,Device issue,Device issues NEC,Device issues,Prod,N
1195,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1196,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1196,2,Irregular breathing,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1196,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1196,4,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1196,5,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1196,6,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1197,1,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1197,2,Sudden hearing loss,Hearing losses,Hearing disorders,Ear,N
1197,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1198,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1199,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1200,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1200,2,Eyelid irritation,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1200,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1201,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1201,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1201,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1201,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1201,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1202,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1203,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1203,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1204,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1204,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1204,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1204,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1204,5,Product packaging confusion,Product confusion errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1204,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1204,7,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1205,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1205,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1205,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1205,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1206,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1206,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1206,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1207,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1207,2,Headache,Headaches NEC,Headaches,Nerv,N
1207,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1208,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1208,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1208,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1208,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1208,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1208,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1208,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1209,1,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1209,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1209,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1210,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1211,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1211,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1212,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1212,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1212,3,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1213,1,Headache,Headaches NEC,Headaches,Nerv,N
1213,2,Migraine,Migraine headaches,Headaches,Nerv,N
1214,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1215,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1216,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1216,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1216,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1217,1,Migraine,Migraine headaches,Headaches,Nerv,N
1218,1,Headache,Headaches NEC,Headaches,Nerv,N
1218,2,Paranasal sinus discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1219,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1220,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1220,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1220,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1220,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1221,1,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1221,2,Superior vena cava occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1222,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1222,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1222,3,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1222,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1222,5,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
1222,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1222,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1223,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1223,2,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1224,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1224,2,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
1224,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1225,1,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
1226,1,Anterior chamber fibrin,Chambers (anterior and posterior) and lens infections and inflammations,"Ocular infections, irritations and inflammations",Eye,N
1226,2,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1226,3,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1226,4,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1226,5,Deep anterior chamber of the eye,"Anterior chamber structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1226,6,Device deposit issue,Device physical property and chemical issues,Device issues,Prod,N
1226,7,Flat anterior chamber of eye,"Anterior chamber structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1226,8,Lens dislocation,"Lens structural change, deposit and degeneration (excl cataracts)","Anterior eye structural change, deposit and degeneration",Eye,N
1226,9,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1226,10,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1226,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1227,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1227,2,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,Y
1227,3,Headache,Headaches NEC,Headaches,Nerv,N
1227,4,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1227,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1228,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1228,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1228,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1228,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1229,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1230,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1230,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1230,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1231,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1231,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1232,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1232,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1233,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1233,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1233,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1233,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1234,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1234,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1234,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1235,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1235,2,Deafness permanent,Hearing losses,Hearing disorders,Ear,N
1235,3,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
1235,4,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1235,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1235,6,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1235,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1235,8,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
1236,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1237,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1238,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1238,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1239,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1240,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1241,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1241,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1241,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1241,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1241,5,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1241,6,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1241,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1241,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1242,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1243,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1243,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1244,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1244,2,Faecaloma,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1244,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1245,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1245,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1246,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1247,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1247,2,Bone cancer,Bone neoplasms malignant (excl sarcomas),Skeletal neoplasms malignant and unspecified,Neopl,N
1247,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1247,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1247,5,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1247,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1247,7,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1247,8,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1247,9,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1247,10,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1247,11,Renal neoplasm,Urinary tract neoplasms unspecified malignancy NEC,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1247,12,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1248,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1248,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1249,1,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
1249,2,Scrotal oedema,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
1250,1,Brain empyema,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1250,2,Central nervous system infection,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1251,1,Actinic keratosis,Skin preneoplastic conditions NEC,Cornification and dystrophic skin disorders,Skin,N
1251,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1251,3,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1251,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1251,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1252,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1252,2,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
1252,3,Ocular surface disease,Ocular disorders NEC,Eye disorders NEC,Eye,N
1253,1,Cortisol decreased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
1253,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1254,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
1255,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1255,2,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1255,3,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1256,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1257,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1258,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1259,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1260,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1260,2,Headache,Headaches NEC,Headaches,Nerv,N
1260,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1260,4,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1261,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1262,1,Headache,Headaches NEC,Headaches,Nerv,N
1263,1,Headache,Headaches NEC,Headaches,Nerv,N
1264,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1265,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1265,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1266,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1266,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1267,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1267,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1267,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
1267,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1268,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1268,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1268,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1268,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1268,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1268,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1268,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1269,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1269,2,Headache,Headaches NEC,Headaches,Nerv,N
1269,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1269,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1269,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1270,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1271,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1272,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1273,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1274,1,Headache,Headaches NEC,Headaches,Nerv,N
1275,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1275,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1275,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1276,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1277,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1277,2,Ocular toxicity,Ocular injuries NEC,Ocular injuries,Eye,N
1277,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1278,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1278,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1279,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1279,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1280,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1280,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1281,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1282,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1282,2,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1283,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1283,2,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1284,1,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
1285,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1285,2,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1285,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1285,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1286,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1286,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1286,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1287,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1287,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1287,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1287,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1287,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1287,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1287,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1287,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1287,9,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1287,10,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1287,11,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1287,12,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1287,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1287,14,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1287,15,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1288,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1288,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1288,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1288,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1288,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1288,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1288,7,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1288,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1289,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1289,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
1289,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1290,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1290,2,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1291,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1292,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1293,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1293,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1293,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1293,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1293,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1293,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1293,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1293,8,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1293,9,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1294,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1294,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1295,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1296,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1296,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1296,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1296,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1296,5,Tumour perforation,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,Y
1297,1,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
1297,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1298,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
1298,2,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1298,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1299,1,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1299,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1300,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1301,1,Device dislocation,Device issues NEC,Device issues,Prod,N
1301,2,Pseudophakic bullous keratopathy,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1301,3,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1301,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1302,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
1302,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1303,1,Decreased immune responsiveness,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1303,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,Y
1303,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1303,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1304,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1304,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1304,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1304,4,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1305,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1306,1,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1306,2,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1307,1,"Brief psychotic disorder, with postpartum onset",Brief psychotic disorder,Schizophrenia and other psychotic disorders,Psych,N
1307,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1308,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1309,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1309,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1309,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1309,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1309,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1310,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1310,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1310,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1310,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1310,5,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1310,6,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1311,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1311,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1312,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1312,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1312,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1312,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1312,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1312,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1313,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1313,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1313,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1314,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1314,2,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1315,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1315,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1315,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1316,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1317,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1317,2,Myopathy,Myopathies,Muscle disorders,Musc,N
1317,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1318,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1318,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1318,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1318,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1318,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1318,6,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1318,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1318,8,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1318,9,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1319,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1320,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1320,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1320,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1321,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
1321,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1321,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1322,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1322,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1323,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
1323,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1324,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1324,2,Headache,Headaches NEC,Headaches,Nerv,N
1324,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1324,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1324,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1325,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1325,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1325,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1325,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1326,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1326,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1327,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1327,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1327,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1327,4,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1327,5,Spinal cord disorder,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1328,1,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1328,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1328,3,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1328,4,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
1329,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1329,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1329,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1329,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1330,1,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1331,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1331,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1331,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1331,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1332,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1333,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1333,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1333,3,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
1333,4,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1334,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1334,2,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1335,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1335,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1335,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1336,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1337,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1337,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1338,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1338,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1338,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1338,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1338,5,Nail bed infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1338,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1338,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1338,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1338,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1339,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1339,2,Pituitary-dependent Cushing's syndrome,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
1339,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1339,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1340,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1341,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1342,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1342,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1342,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1342,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1342,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1342,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1342,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1342,8,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1342,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1343,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1343,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1343,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1343,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1343,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1343,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1344,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1345,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1346,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1347,1,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
1348,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1348,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1349,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1349,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1349,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1350,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1350,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1351,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1351,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1351,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1351,4,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1351,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1352,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1353,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1354,1,Invasive lobular breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1354,2,Lobular breast carcinoma in situ,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1354,3,Phyllodes tumour,Breast neoplasms unspecified malignancy,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1355,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1356,1,Adenocarcinoma gastric,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
1356,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1356,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1357,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1357,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1357,3,Pathological fracture,Fractures NEC,Fractures,Musc,N
1358,1,Acanthamoeba keratitis,Amoebic infections,Protozoal infectious disorders,Infec,N
1358,2,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1358,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1358,4,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1359,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1359,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1360,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1360,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1360,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1360,4,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
1360,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1361,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1362,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1363,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1363,2,Breath odour,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1363,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1363,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1363,5,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1363,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1363,7,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1363,8,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1363,9,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1363,10,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1363,11,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1363,12,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1363,13,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1363,14,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
1364,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1365,1,Vomiting projectile,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1366,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1366,2,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1367,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1368,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1369,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1370,1,Dandruff,Scaly conditions,Epidermal and dermal conditions,Skin,N
1370,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1371,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1371,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1371,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1372,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1373,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1373,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1373,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1373,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1374,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1374,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1374,3,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1374,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1374,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1374,6,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1374,7,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1375,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1376,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1376,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1376,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1377,1,Bone lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1377,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1377,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1377,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1377,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1378,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1378,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1378,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1379,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1379,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1380,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1380,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1381,1,Non-infectious endophthalmitis,Chambers (anterior and posterior) and lens infections and inflammations,"Ocular infections, irritations and inflammations",Eye,N
1382,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1382,2,Headache,Headaches NEC,Headaches,Nerv,N
1382,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1383,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1384,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1384,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1384,3,Loss of visual contrast sensitivity,Visual disorders NEC,Vision disorders,Eye,N
1384,4,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
1384,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1384,6,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1385,1,Migraine,Migraine headaches,Headaches,Nerv,N
1385,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1386,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
1386,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1386,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1386,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1387,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1388,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1388,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1388,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1388,4,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1389,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1389,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1389,3,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1389,4,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1389,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1389,6,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1389,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1390,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1391,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1391,2,Bile acid malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1391,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1391,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1391,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1391,6,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1391,7,Radius fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1392,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1393,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1394,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1394,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1394,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1394,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1395,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1395,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1395,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1396,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1396,2,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1396,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1396,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1396,5,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1396,6,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1396,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1396,8,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1397,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1397,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1397,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1397,4,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1398,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1398,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1399,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1399,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1400,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1401,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1402,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1402,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1403,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1403,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1404,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1404,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1405,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1406,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1406,2,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1406,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1407,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1407,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1408,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1409,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1410,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1410,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1411,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1412,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1412,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1412,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1412,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1412,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1412,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1412,7,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1412,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1413,1,Apraxia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1414,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1415,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1415,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1416,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1417,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1418,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1418,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1419,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1419,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1420,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1420,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1420,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1421,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1421,2,Device dislocation,Device issues NEC,Device issues,Prod,N
1421,3,Product residue present,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1421,4,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
1421,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1422,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1422,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1422,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1422,4,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1422,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1422,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1422,7,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1422,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1423,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1424,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1424,2,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1424,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1424,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1424,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1424,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
1424,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1424,8,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1425,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1426,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1426,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1426,3,Headache,Headaches NEC,Headaches,Nerv,N
1426,4,Hyphaema,Eye injuries NEC,Injuries NEC,Inj&P,N
1426,5,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1426,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1427,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1427,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1427,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1428,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1429,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1430,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1430,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1430,3,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1430,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1430,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1430,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1430,7,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
1430,8,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1430,9,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1431,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1431,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1431,3,Recalled product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1432,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1433,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1433,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1433,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1433,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1433,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1433,6,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1433,7,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1433,8,Natural killer-cell lymphoblastic lymphoma,Precursor T-lymphoblastic lymphomas/leukaemias,Lymphomas non-Hodgkin's T-cell,Neopl,N
1433,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1433,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1434,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1435,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1436,1,Hyphaema,Eye injuries NEC,Injuries NEC,Inj&P,N
1436,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1436,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1437,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1438,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1439,1,Headache,Headaches NEC,Headaches,Nerv,N
1440,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1440,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1441,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1441,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1441,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1441,4,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1441,5,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1442,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1442,2,Headache,Headaches NEC,Headaches,Nerv,N
1442,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1442,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1442,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1443,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1444,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1445,1,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1446,1,Conjunctival retraction,Eye injuries NEC,Injuries NEC,Inj&P,N
1446,2,Symblepharon,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1447,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1447,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1447,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1448,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1449,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1449,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
1450,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1451,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1452,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1453,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1453,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1453,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1453,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1454,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1454,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1454,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1455,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1456,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1457,1,Band neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1457,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1457,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1457,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1458,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1458,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1459,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1459,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1459,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1459,4,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1459,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
1459,6,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1460,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1461,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1461,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1462,1,Child-Pugh-Turcotte score abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1462,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1462,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1462,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1462,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1463,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1463,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1464,1,Encephalitis enteroviral,Enteroviral infections NEC,Viral infectious disorders,Infec,N
1465,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1465,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1465,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1465,4,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1466,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1467,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1468,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1468,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1469,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1469,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1469,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1469,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1469,5,Fear of death,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1469,6,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
1470,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1470,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1470,3,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1470,4,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1470,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1470,6,Retinal ischaemia,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1471,1,Fracture,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1471,2,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1472,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1473,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1474,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1474,2,Headache,Headaches NEC,Headaches,Nerv,N
1474,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1474,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1475,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1476,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1476,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1476,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1476,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1476,5,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1476,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1476,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1476,8,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1476,9,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1476,10,Testicular germ cell cancer metastatic,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1476,11,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1477,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1478,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1479,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1479,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1480,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1480,2,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1480,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1480,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1480,5,Headache,Headaches NEC,Headaches,Nerv,N
1480,6,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1480,7,Keratic precipitates,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1480,8,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1480,9,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1480,10,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1480,11,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1481,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1481,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1481,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1481,4,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1481,5,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1481,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1482,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1482,2,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
1482,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1483,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1484,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1484,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1485,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1485,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1486,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1487,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1487,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1487,3,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1487,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1488,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1488,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1488,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1489,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1489,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1489,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1489,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1490,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1490,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1491,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1492,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1492,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1493,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1493,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1494,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1495,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1495,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1495,3,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1495,4,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1496,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1496,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1497,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1497,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1498,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1498,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1498,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1498,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1499,1,Mantle cell lymphoma recurrent,Mantle cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1500,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1501,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1501,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1502,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1502,2,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1503,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1504,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1504,2,Eye contusion,Eye injuries NEC,Injuries NEC,Inj&P,N
1504,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1504,4,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1504,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1504,6,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1504,7,Headache,Headaches NEC,Headaches,Nerv,N
1504,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1504,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1504,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1505,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1506,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
1506,2,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
1507,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1507,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1508,1,Device dislocation,Device issues NEC,Device issues,Prod,N
1509,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1509,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1510,1,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1510,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1511,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1511,2,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1511,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1512,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1513,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1514,1,Corneal opacity,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1514,2,Corneal thickening,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1514,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1514,4,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1514,5,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1515,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1516,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1517,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1518,1,Actinomycosis,Actinomycotic infectious disorders,Bacterial infectious disorders,Infec,N
1518,2,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1518,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1518,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1519,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1520,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1520,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1520,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1520,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1520,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1520,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1521,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1521,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1522,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1523,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1524,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1524,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1525,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1526,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1526,2,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1527,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1528,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1528,2,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1528,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1529,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1529,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1530,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1531,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1532,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1532,2,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
1533,1,Device dislocation,Device issues NEC,Device issues,Prod,N
1533,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1534,1,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
1535,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1535,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1536,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1537,1,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
1538,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
1539,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1540,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1540,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1541,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1541,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1542,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1542,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1543,1,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1544,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1544,2,Seborrhoeic keratosis,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1544,3,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1545,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1546,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1547,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1547,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1547,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1547,4,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,Y
1547,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1548,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1549,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1549,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1549,3,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1549,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1549,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1550,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1550,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1550,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1550,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1551,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1551,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1552,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1552,2,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1552,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1553,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1553,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1553,3,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1553,4,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1553,5,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1553,6,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1553,7,Angle closure glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1553,8,Anterior chamber inflammation,Chambers (anterior and posterior) and lens infections and inflammations,"Ocular infections, irritations and inflammations",Eye,N
1553,9,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1553,10,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1553,11,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1553,12,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1553,13,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1553,14,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1553,15,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1553,16,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1553,17,Central vision loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1553,18,Central vision loss,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1553,19,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1553,20,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1553,21,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1553,22,Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1553,23,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1553,24,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1553,25,Epiretinal membrane,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1553,26,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1553,27,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1553,28,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1553,29,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1553,30,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1553,31,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1553,32,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1553,33,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1553,34,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1553,35,Headache,Headaches NEC,Headaches,Nerv,N
1553,36,Headache,Headaches NEC,Headaches,Nerv,N
1553,37,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1553,38,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1553,39,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1553,40,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1553,41,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1553,42,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1553,43,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1553,44,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1553,45,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1553,46,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1553,47,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1553,48,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1553,49,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1553,50,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1553,51,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1553,52,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1553,53,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1553,54,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1553,55,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1553,56,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1553,57,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1553,58,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1553,59,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1553,60,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1553,61,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1553,62,Uveitis-glaucoma-hyphaema syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1554,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1554,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1554,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1554,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1555,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1556,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1557,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1557,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1558,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1558,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1559,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1560,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1561,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1561,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1561,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1561,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1561,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1562,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1563,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1563,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1564,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1564,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1565,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1565,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1565,3,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
1566,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1566,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1566,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1567,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1568,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1569,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1570,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1570,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1570,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1571,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1572,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1572,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1573,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1574,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1574,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1574,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1575,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1576,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1577,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1578,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1578,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1579,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1579,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1579,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1579,4,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
1579,5,Fungal test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
1579,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1579,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1579,8,Respirovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1580,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1580,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1581,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1581,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1581,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1581,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1581,5,Genital burning sensation,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1581,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1581,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1581,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1581,9,Pressure of speech,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
1581,10,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1582,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1583,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1584,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1585,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1585,2,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1585,3,Radius fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1585,4,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1586,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1586,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1586,3,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
1586,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1586,5,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,Y
1586,6,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1586,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1586,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1586,9,Right atrial hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1586,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1586,11,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1587,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1587,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1588,1,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
1589,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1590,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1591,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1591,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1592,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1593,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1594,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1594,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1594,3,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1594,4,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1595,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1595,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1595,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1596,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1597,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1597,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1597,3,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1598,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1598,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1599,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1599,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1599,3,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1600,1,Ear congestion,Ear disorders NEC,Aural disorders NEC,Ear,N
1600,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1600,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1600,4,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1600,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1601,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1601,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1602,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1603,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1603,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1603,3,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1604,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1604,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1604,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1605,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1606,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1606,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1606,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1607,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1608,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1608,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1608,3,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1609,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
1610,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1611,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1611,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1612,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1613,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1613,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1614,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1614,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1615,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1616,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1616,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1616,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1616,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1617,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1617,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1617,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1617,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1617,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1618,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1618,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1618,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1618,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1619,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1619,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1619,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1619,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1619,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1620,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1620,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1620,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1620,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1621,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1621,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
1622,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1622,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1622,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1622,4,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1623,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1623,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,Y
1623,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1624,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1624,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1624,3,Intestinal ischaemia,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
1624,4,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1625,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1626,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1627,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1628,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1628,2,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1629,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1630,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1630,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1630,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1630,4,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1631,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1632,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1633,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1634,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1635,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1635,2,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1636,1,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1637,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1637,2,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1638,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1638,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1639,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1639,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1640,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1640,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1641,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1641,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1641,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1642,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1642,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1643,1,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1644,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1645,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1645,2,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1646,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1646,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1647,1,Administration site irritation,Administration site reactions NEC,Administration site reactions,Genrl,N
1647,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1647,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1648,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1649,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
1650,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1650,2,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1651,1,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1652,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1653,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1653,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1654,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1654,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1654,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1654,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1655,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1655,2,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1655,3,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
1655,4,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1656,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1657,1,Conjunctivitis allergic,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1657,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1657,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1658,1,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
1659,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1660,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1661,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1661,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1661,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1661,4,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1661,5,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1661,6,Parainfluenzae virus infection,Parainfluenzae viral infections,Viral infectious disorders,Infec,N
1661,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1661,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1662,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1663,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1663,2,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
1663,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1663,4,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1664,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1664,2,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1665,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1666,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1666,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1666,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1667,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1667,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1667,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1668,1,Device physical property issue,Device physical property and chemical issues,Device issues,Prod,N
1668,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1668,3,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1668,4,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1669,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1670,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1670,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1670,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1670,4,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1670,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1671,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1672,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1672,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1672,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1673,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1674,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1674,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1674,3,Headache,Headaches NEC,Headaches,Nerv,N
1674,4,Melanoma recurrent,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1674,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1674,6,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1674,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1674,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1675,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1675,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1675,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1675,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1675,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1676,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1677,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1678,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1678,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1679,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1680,1,Secondary adrenocortical insufficiency,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
1681,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1682,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1683,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1683,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1683,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1683,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1683,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
1683,6,Respiratory tract haemorrhage,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1683,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1684,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1685,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1685,2,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1685,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1685,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1686,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1687,1,Headache,Headaches NEC,Headaches,Nerv,N
1688,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1688,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1688,3,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1688,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1689,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1689,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1690,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1691,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1691,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1691,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1692,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1692,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
1692,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1692,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1693,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1694,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1694,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1694,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1694,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1695,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1695,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1696,1,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1697,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1697,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1697,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1697,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1698,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
1699,1,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1699,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,Y
1700,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1700,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1701,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1702,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1702,2,Product container issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1703,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1704,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1704,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1705,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1705,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1706,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1707,1,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1707,2,Eyelid pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1708,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1709,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1709,2,Deafness,Hearing losses,Hearing disorders,Ear,N
1710,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1711,1,Retinal pigment epitheliopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1712,1,Retinal pigment epitheliopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1713,1,Persistent corneal epithelial defect,Eye injuries NEC,Injuries NEC,Inj&P,N
1714,1,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1714,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1714,3,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1715,1,Retinal pigment epitheliopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1716,1,Retinal pigment epitheliopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1717,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
1718,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1719,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1720,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1720,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1720,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1720,4,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1720,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1721,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1722,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1722,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1723,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1724,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1724,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1724,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1724,4,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1724,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1724,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1724,7,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1725,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1725,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1725,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1725,4,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1725,5,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1725,6,Histiocytic sarcoma,Histiocytoses,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1725,7,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1725,8,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1725,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1725,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1726,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1726,2,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1726,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1726,4,Cellulitis orbital,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1726,5,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
1726,6,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1726,7,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1726,8,Headache,Headaches NEC,Headaches,Nerv,N
1726,9,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1726,10,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1726,11,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1726,12,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
1726,13,Infection susceptibility increased,Infections NEC,Infections - pathogen unspecified,Infec,N
1726,14,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1726,15,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1726,16,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1726,17,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1726,18,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1726,19,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
1726,20,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1726,21,Uveitis-glaucoma-hyphaema syndrome,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1727,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1727,2,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
1727,3,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1728,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1728,2,Immune-mediated encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
1728,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1728,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1728,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1728,6,Toxic leukoencephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
1729,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1729,2,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1729,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1729,4,Eyelid disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
1729,5,Eyelid pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1729,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1729,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1730,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
1730,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1731,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1731,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1732,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1732,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1733,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1733,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1733,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1734,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1734,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1735,1,Malignant pleural effusion,Pleural neoplasms,Pleural disorders,Resp,N
1735,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1736,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1737,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1737,2,Drop attacks,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
1737,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1737,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1737,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1738,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1738,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1738,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1738,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1738,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1739,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1739,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1739,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1740,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1740,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1740,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1740,4,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1740,5,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1740,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1741,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1741,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,Y
1742,1,Device dislocation,Device issues NEC,Device issues,Prod,N
1742,2,Foreign body in eye,Eye injuries NEC,Injuries NEC,Inj&P,N
1742,3,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
1742,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1743,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1743,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1744,1,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1744,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1745,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1745,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1745,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1745,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1745,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1745,6,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1745,7,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1745,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1745,9,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1745,10,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1745,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1745,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
1745,13,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1745,14,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1745,15,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1745,16,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1745,17,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1745,18,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1745,19,Small fibre neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1745,20,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1745,21,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
1745,22,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1746,1,Migraine,Migraine headaches,Headaches,Nerv,N
1746,2,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1747,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1747,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1748,1,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1748,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1749,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1749,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1750,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1750,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1750,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1750,4,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
1751,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1751,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1751,3,Oroantral fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1751,4,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1751,5,Periodontal disease,Dental disorders NEC,Dental and gingival conditions,Gastr,N
1751,6,Periodontitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1751,7,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1751,8,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1751,9,Tooth deposit,Dental surface disorders,Dental and gingival conditions,Gastr,N
1752,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1752,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1753,1,Chronic sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1753,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1753,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1753,4,Oroantral fistula,Gastrointestinal fistulae,Gastrointestinal conditions NEC,Gastr,N
1753,5,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1753,6,Periodontitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1753,7,Tooth infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1754,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1754,2,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1755,1,Granulomatous lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1755,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1755,3,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1755,4,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
1755,5,Primary mediastinal large B-cell lymphoma,Primary mediastinal large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1755,6,Sarcoidosis,Acute and chronic sarcoidosis,Immune disorders NEC,Immun,N
1755,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1756,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1756,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1756,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1756,4,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1756,5,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1756,6,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1756,7,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1756,8,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1756,9,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1756,10,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1756,11,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1756,12,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1756,13,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1756,14,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1756,15,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1756,16,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1756,17,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
1756,18,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
1756,19,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1756,20,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1756,21,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1756,22,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1756,23,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
1756,24,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1756,25,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1756,26,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1756,27,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1756,28,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
1756,29,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1756,30,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1756,31,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1756,32,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1756,33,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1756,34,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1756,35,Radiation inflammation,Radiation injuries,Injuries by physical agents,Inj&P,N
1756,36,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1756,37,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,Y
1756,38,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1757,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1757,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1757,3,Uterine pain,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1758,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1759,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1759,2,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
1759,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1759,4,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1759,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1760,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1761,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1761,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1762,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1763,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1764,1,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,Y
1765,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1766,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1766,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1767,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1767,2,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1767,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1767,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1767,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1767,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1767,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1767,8,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1768,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1769,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1770,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1770,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1770,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1771,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1771,2,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
1771,3,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1772,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1772,2,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,Y
1773,1,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1774,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1774,2,Deafness transitory,Hearing losses,Hearing disorders,Ear,N
1775,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1775,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1776,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1776,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1776,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1776,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1776,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1776,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1777,1,Ophthalmic herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1777,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1778,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1779,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1780,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1781,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1781,2,Eustachian tube dysfunction,Eustachian tube disorders,Middle ear disorders (excl congenital),Ear,N
1781,3,Headache,Headaches NEC,Headaches,Nerv,N
1781,4,Inner ear inflammation,Inner ear infections and inflammations,Inner ear and VIIIth cranial nerve disorders,Ear,N
1781,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1782,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1782,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1782,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1782,4,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1782,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1783,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1784,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1785,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1785,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1785,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1785,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1786,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1786,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1787,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1787,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1787,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1788,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1789,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1789,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1790,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1791,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1791,2,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1791,3,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1792,1,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1792,2,Acne,Acnes,Skin appendage conditions,Skin,N
1792,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1792,4,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1792,5,Pharyngitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
1792,6,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1793,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1794,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1794,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1794,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1794,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1794,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1794,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1795,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1796,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
1797,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
1797,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1798,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
1799,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1799,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1799,3,Cutaneous nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1800,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1801,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1801,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1801,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1801,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1802,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1803,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1804,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1804,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1805,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1806,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1806,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1806,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1807,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1807,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1807,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1807,4,Delirium,Deliria,Deliria (incl confusion),Psych,N
1807,5,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1808,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
1808,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1809,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1809,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1809,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1810,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1810,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1810,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1810,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1810,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1810,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1810,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1810,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1810,9,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1810,10,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1810,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1810,12,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1810,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1810,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1810,15,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1810,16,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1810,17,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1811,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1812,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1812,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1813,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
1814,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
1814,2,Skull fracture,"Skull fractures, facial bone fractures and dislocations",Bone and joint injuries,Inj&P,N
1815,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1815,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1815,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1816,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1816,2,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1816,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1817,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1818,1,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1818,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1818,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1818,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1818,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1818,6,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1818,7,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1819,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1820,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1820,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1821,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1821,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1821,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
1821,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1822,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1822,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1822,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1822,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1822,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1823,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1823,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1823,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1824,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1824,2,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1824,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1825,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1825,2,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1825,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1825,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1825,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1825,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1825,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1825,8,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1825,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1825,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1825,11,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1825,12,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1825,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1825,14,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1825,15,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1825,16,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1825,17,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1826,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1826,2,Retinal injury,Eye injuries NEC,Injuries NEC,Inj&P,N
1827,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1828,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1828,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1828,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1828,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1829,1,Headache,Headaches NEC,Headaches,Nerv,N
1830,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1830,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1830,3,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1831,1,Bladder cancer recurrent,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1831,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1831,3,Product solubility abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1832,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1833,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1833,2,Glare,Visual disorders NEC,Vision disorders,Eye,N
1833,3,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1833,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1833,5,Vitreous detachment,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1834,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1834,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1834,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1834,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
1835,1,Epidural lipomatosis,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1835,2,Pituitary-dependent Cushing's syndrome,Anterior pituitary hyperfunction,Hypothalamus and pituitary gland disorders,Endo,N
1836,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1836,2,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1836,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1837,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1838,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1839,1,Glare,Visual disorders NEC,Vision disorders,Eye,N
1839,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1839,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1839,4,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1840,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1840,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1840,3,Dissociative identity disorder,Dissociative states,Dissociative disorders,Psych,N
1840,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1840,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1840,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1840,7,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1840,8,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1841,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1842,1,Prostatic specific antigen increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
1843,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1843,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1843,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1843,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1843,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1843,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1843,7,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1844,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1845,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1845,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1846,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1847,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1847,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1848,1,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1849,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1849,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1849,3,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1849,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1849,5,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1849,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1849,7,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1850,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1850,2,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1851,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1851,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1851,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1852,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1853,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1854,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1854,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1855,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1856,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1856,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
1857,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1857,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1857,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1857,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1857,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1857,6,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1857,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1857,8,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1857,9,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1857,10,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
1857,11,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1858,1,Acne,Acnes,Skin appendage conditions,Skin,N
1858,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1858,3,Headache,Headaches NEC,Headaches,Nerv,N
1858,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1858,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1858,6,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1859,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1859,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1860,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1861,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1862,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1863,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1864,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1864,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1865,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1865,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1865,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1865,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1865,5,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1865,6,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
1865,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1865,8,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1865,9,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1865,10,Enterocolitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1865,11,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1865,12,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1865,13,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1865,14,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1865,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1865,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1865,17,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1865,18,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1865,19,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1865,20,Terminal ileitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1865,21,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1865,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1866,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1867,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1868,1,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1869,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1869,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1870,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1870,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1870,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1870,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
1870,5,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1870,6,Mental fatigue,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1870,7,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1870,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1871,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1871,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1871,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1871,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1871,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1872,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1873,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1874,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1874,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1874,3,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1875,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1875,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1875,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1876,1,Headache,Headaches NEC,Headaches,Nerv,N
1876,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1876,3,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
1876,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1876,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1877,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
1878,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1878,2,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1878,3,Upper airway obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1879,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1879,2,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1879,3,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1880,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1881,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1882,1,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1882,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1882,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1882,4,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1883,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1883,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1883,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1883,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1883,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1883,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1883,7,Food aversion,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1883,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1883,9,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1883,10,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
1883,11,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1883,12,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1883,13,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1883,14,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1883,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1883,16,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
1883,17,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1883,18,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1884,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1884,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1885,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1886,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1886,2,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1887,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1887,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1887,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1887,4,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1887,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1887,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1888,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1889,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1889,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1889,3,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1889,4,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
1889,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1889,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1890,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1890,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1891,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1891,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1892,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1892,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1893,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1893,2,Chillblains,Conditions caused by cold,Injuries by physical agents,Inj&P,N
1893,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1893,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1893,5,Light chain analysis increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
1893,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1893,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1893,8,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1893,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1893,10,Vertebral lesion,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1894,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1894,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1895,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1895,2,Febrile convulsion,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1895,3,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
1895,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1895,5,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1895,6,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1896,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1896,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1897,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1897,2,Nosocomial infection,Infectious transmissions,Ancillary infectious topics,Infec,N
1898,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1899,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1899,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1899,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1899,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1899,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1899,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1899,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1899,8,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1900,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1900,2,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1901,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
1902,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1903,1,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1904,1,Deafness,Hearing losses,Hearing disorders,Ear,N
1904,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1905,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1905,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1905,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1906,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1907,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1907,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1907,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1908,1,Initial insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1909,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1910,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1910,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1910,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1910,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1911,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1912,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1912,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1912,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1913,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1914,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
1915,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1915,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1916,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1917,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1917,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1917,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1917,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1917,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1917,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1917,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1918,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1918,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1919,1,Brain death,Death and sudden death,Fatal outcomes,Genrl,Y
1919,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1919,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1919,4,Headache,Headaches NEC,Headaches,Nerv,N
1919,5,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1919,6,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1919,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1919,8,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1919,9,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1919,10,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1920,1,Headache,Headaches NEC,Headaches,Nerv,N
1920,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1920,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1920,4,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1921,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1921,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1922,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1922,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1922,3,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1922,4,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1923,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1924,1,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1924,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1925,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1925,2,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1925,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1925,4,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1925,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1925,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1925,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1925,8,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1926,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1926,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1926,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1926,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1927,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1927,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1927,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1927,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1928,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1928,2,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1929,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1930,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1930,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1930,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1931,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
1932,1,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1932,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1933,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1933,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1934,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1935,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1936,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1936,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1936,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1937,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1937,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1937,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1937,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1937,5,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1938,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1938,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1938,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1938,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1938,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1938,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1938,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1938,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1938,9,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1939,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1939,2,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1939,3,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1940,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1940,2,Central serous chorioretinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1941,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1942,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1942,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1942,3,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
1942,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1943,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1943,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1943,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1944,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1944,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1944,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1944,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1945,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1945,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1945,3,Vestibular disorder,Inner ear disorders NEC,Inner ear and VIIIth cranial nerve disorders,Ear,N
1946,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1947,1,Iris discolouration,"Iris and ciliary body structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1948,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1948,2,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1949,1,Ectropion,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
1949,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1949,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
1949,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1950,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1951,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1951,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1952,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1953,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1954,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1955,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1956,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1956,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1956,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1956,4,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
1956,5,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1956,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1956,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1956,8,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1956,9,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1956,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1956,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1956,12,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1957,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1957,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1958,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1959,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1959,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1960,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1960,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1960,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1960,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1960,5,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1960,6,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1961,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1961,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1961,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1961,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1962,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1962,2,Hypoperfusion,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1962,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1962,4,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1963,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1963,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1963,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
1964,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1964,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1964,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1965,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1966,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1967,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1968,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1968,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1968,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1969,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1970,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1970,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1970,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1970,4,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1970,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1970,6,Ureterolithiasis,Urinary tract lithiasis NEC,Urolithiases,Renal,N
1970,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1971,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1971,2,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1971,3,Ophthalmic herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1972,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1972,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1972,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1973,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1973,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1974,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
1975,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1975,2,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
1975,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
1975,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1975,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1976,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1976,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1977,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1977,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1977,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1978,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1978,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1978,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1979,1,Community acquired infection,Infectious transmissions,Ancillary infectious topics,Infec,N
1979,2,Conjunctival erosion,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1979,3,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1979,4,Corneal epithelium defect,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1979,5,Corneal lesion,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
1979,6,Erythema of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1979,7,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1979,8,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
1979,9,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1979,10,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
1979,11,Ophthalmic herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
1979,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1979,13,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1980,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1980,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1980,3,Paraproteinaemia,Plasma cell neoplasms NEC,Plasma cell neoplasms,Neopl,N
1980,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1981,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1981,2,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1981,3,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1982,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1982,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1983,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1984,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1985,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1985,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1986,1,Abdominal sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1986,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1986,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1986,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1987,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1988,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1989,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1990,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1990,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
1990,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1990,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1990,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1990,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1990,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1990,8,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1990,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
1991,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1991,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1992,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1993,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1993,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1993,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1994,1,Orbital swelling,"Orbital structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1994,2,Periorbital discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
1995,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1995,2,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1995,3,Headache,Headaches NEC,Headaches,Nerv,N
1995,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1995,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1995,6,Visual field defect,Visual field disorders,Vision disorders,Eye,N
1996,1,Product after taste,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1996,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1997,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1998,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1998,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1998,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1998,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1999,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1999,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1999,3,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
1999,4,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1999,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1999,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2000,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2001,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2002,1,17-hydroxyprogesterone increased,Adrenal cortex tests,Endocrine investigations (incl sex hormones),Inv,N
2002,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2002,3,Benign neoplasm of adrenal gland,Adrenal neoplasms benign,Endocrine neoplasms benign,Neopl,N
2002,4,Blood corticotrophin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
2003,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
2004,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2005,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
2005,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2006,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2007,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2007,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2007,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2008,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2008,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2008,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
2008,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2008,5,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
2008,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2009,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2010,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2010,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2010,3,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2010,4,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2010,5,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2010,6,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2010,7,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
2010,8,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
2010,9,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
2010,10,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
2010,11,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2010,12,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2010,13,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
2010,14,Brain stem glioma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
2010,15,Brain stem glioma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
2010,16,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2010,17,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2010,18,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2010,19,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2010,20,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2010,21,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2010,22,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2010,23,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2010,24,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
2010,25,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2010,26,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2010,27,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2010,28,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2010,29,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2010,30,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2010,31,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2010,32,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2010,33,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2010,34,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2010,35,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2010,36,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2010,37,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2010,38,Reflux gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2010,39,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2010,40,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2011,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2011,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2011,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2012,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2013,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2014,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2015,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
2015,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
2015,3,Central nervous system fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2016,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2017,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2017,2,Dacryocanaliculitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2017,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2017,4,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2017,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2017,6,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2017,7,Keratitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
2017,8,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2018,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2018,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2018,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2019,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2019,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2019,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
2019,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2019,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2019,6,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2020,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2020,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2021,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
2021,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
2022,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2022,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2022,3,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2022,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2022,5,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2022,6,Loss of bladder sensation,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
2022,7,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2022,8,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2022,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2023,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2023,2,Epidermolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
2023,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2023,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2023,5,Necrotising fasciitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
2023,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2023,7,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2023,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2023,9,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2023,10,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2023,11,Soft tissue swelling,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2024,1,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2025,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2025,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2025,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2025,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2026,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2026,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2027,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2027,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
2027,3,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2028,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2028,2,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2029,1,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2029,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2029,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2030,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2031,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2031,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2031,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2032,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2032,2,Lip pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2032,3,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2032,4,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2032,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2032,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2033,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2033,2,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2034,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2034,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2034,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2034,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2034,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2035,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2035,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2035,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2036,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2036,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2036,3,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2036,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2036,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2037,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2037,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
2037,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2038,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2038,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2038,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2038,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2038,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2038,6,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2038,7,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2038,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2038,9,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2038,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2039,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2039,2,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
2039,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2040,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2041,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2042,1,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2042,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2043,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
2043,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2043,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2043,4,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2043,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2043,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2044,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2044,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2044,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2045,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2046,1,Corneal decompensation,Corneal disorders NEC,Eye disorders NEC,Eye,N
2046,2,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2046,3,Device dislocation,Device issues NEC,Device issues,Prod,N
2046,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2046,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2047,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2047,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2048,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2049,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2049,2,Headache,Headaches NEC,Headaches,Nerv,N
2050,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2050,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2050,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2050,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2050,5,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2050,6,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2050,7,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2050,8,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2050,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2050,10,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2050,11,Myalgia,Muscle pains,Muscle disorders,Musc,N
2050,12,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2050,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2050,14,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2051,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2052,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2053,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2053,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2053,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2054,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2054,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2054,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2055,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2056,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2057,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2057,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2057,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2057,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2057,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2058,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2058,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2058,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2058,4,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2058,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2058,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2059,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2060,1,Cellulitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
2060,2,Necrotising fasciitis streptococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
2061,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2061,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2061,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2062,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2063,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2064,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2064,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2064,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2065,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2065,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2066,1,Pericarditis constrictive,Noninfectious pericarditis,Pericardial disorders,Card,N
2067,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2068,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
2069,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2069,2,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
2069,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2070,1,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2070,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2071,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2071,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2072,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2072,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2072,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2073,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
2074,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2075,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2076,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2077,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2077,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2078,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2078,2,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2079,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2079,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2079,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2080,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2081,1,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2081,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2081,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2082,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2082,2,Allergic respiratory symptom,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
2082,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2082,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2082,5,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2082,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2082,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2082,8,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2082,9,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2083,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2084,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2085,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2085,2,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2085,3,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2085,4,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2085,5,Alcohol abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2085,6,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2085,7,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2085,8,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2085,9,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2085,10,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2085,11,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2085,12,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2085,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2085,14,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2085,15,Intentional device misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2085,16,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2085,17,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2085,18,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2085,19,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2085,20,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2085,21,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2086,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2087,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2088,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2089,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2090,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2090,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2090,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2090,4,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2090,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2090,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2091,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2091,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2092,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2092,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2093,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2093,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
2094,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2095,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2096,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2096,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2096,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2097,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2098,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2099,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2100,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2100,2,Headache,Headaches NEC,Headaches,Nerv,N
2100,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2101,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2101,2,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
2102,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2102,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2102,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2102,4,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2103,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2103,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2103,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2104,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2104,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2105,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2105,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2106,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
2106,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2106,3,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2106,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2106,5,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2106,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2107,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2108,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2109,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
2109,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2110,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2111,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
2111,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
2111,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2111,4,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2111,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2111,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2111,7,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2111,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2112,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2113,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2114,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2115,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2116,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2116,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2116,3,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2116,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2117,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2117,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2118,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2119,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2119,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2120,1,Headache,Headaches NEC,Headaches,Nerv,N
2121,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2122,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2122,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2122,3,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2123,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
2124,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2124,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2124,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2124,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2124,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2124,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2124,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2124,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2124,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2124,10,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2125,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2125,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2125,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2125,4,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2126,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2127,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2127,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2127,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2128,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2128,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2129,1,Central nervous system lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
2129,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2129,3,Headache,Headaches NEC,Headaches,Nerv,N
2129,4,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
2129,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2129,6,Symptom masked,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2129,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2130,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2130,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2131,1,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2132,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2132,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2133,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2134,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2134,2,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2134,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2134,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2135,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2135,2,Vein rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2136,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2136,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2136,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2136,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2136,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2136,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2137,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2137,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2137,3,Sweating fever,Viral infections NEC,Viral infectious disorders,Infec,N
2138,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2138,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2139,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2139,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2140,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2141,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2142,1,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2143,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2144,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2144,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2144,3,Headache,Headaches NEC,Headaches,Nerv,N
2144,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2144,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2145,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2145,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2145,3,Creatinine renal clearance decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2145,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2145,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2145,6,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2145,7,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
2145,8,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2145,9,Varicophlebitis,Varicose veins NEC,Venous varices,Vasc,N
2146,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2147,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2148,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2149,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2150,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2150,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2150,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2150,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2150,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2150,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2150,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2150,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2151,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
2151,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2152,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2152,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
2152,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2153,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2154,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2155,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2155,2,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
2155,3,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2156,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2157,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2157,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2157,3,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
2158,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2158,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2158,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2159,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2159,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2159,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2160,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2161,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2162,1,Personality disorder,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
2163,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2163,2,Barrett's oesophagus,Gastrointestinal mucosal dystrophies and secretion disorders,Gastrointestinal conditions NEC,Gastr,N
2163,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2163,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2163,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2163,6,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2163,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2163,8,Regurgitation,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2163,9,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
2164,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2164,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2164,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2164,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2164,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2165,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2165,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2166,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2166,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2167,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2168,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2169,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2170,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2170,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2170,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
2170,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2170,5,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
2170,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2170,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2170,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2170,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2170,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2171,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2171,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2172,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2172,2,Pneumonia klebsiella,Klebsiella infections,Bacterial infectious disorders,Infec,Y
2173,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
2173,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
2173,3,West Nile viral infection,Flaviviral infections,Viral infectious disorders,Infec,N
2174,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2174,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2175,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2176,1,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2177,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2177,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2178,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2178,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2178,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2178,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2179,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2179,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2179,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2179,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2179,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2179,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2179,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2180,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2180,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2180,3,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2180,4,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2181,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2181,2,Autonomic neuropathy,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
2181,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2181,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2181,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2181,6,Ileus paralytic,Non-mechanical ileus,Gastrointestinal motility and defaecation conditions,Gastr,N
2181,7,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2181,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2181,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2181,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2181,11,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
2181,12,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2182,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2183,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2183,2,Immunoglobulins decreased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
2183,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2183,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2183,5,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2184,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2185,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2185,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2186,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2186,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2186,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2187,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2187,2,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
2188,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2188,2,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
2189,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2190,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2191,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2192,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2193,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2194,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2194,2,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
2195,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2196,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
2196,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2197,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2197,2,Autophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
2197,3,Deafness,Hearing losses,Hearing disorders,Ear,N
2197,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2198,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2198,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2199,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2199,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2199,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2199,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2199,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2199,6,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
2199,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2200,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2200,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2201,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
2202,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
2203,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
2204,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2205,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2205,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2205,3,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2206,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2207,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2208,1,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2209,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2209,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2209,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2209,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2209,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2209,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2209,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2210,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2211,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2212,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2213,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2213,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2214,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2214,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2215,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2215,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2216,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2216,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2216,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2216,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2216,5,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2217,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2218,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2218,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2218,3,Headache,Headaches NEC,Headaches,Nerv,N
2219,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2219,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2220,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2220,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2221,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
2221,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2221,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2222,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2223,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2223,2,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
2224,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2225,1,Sickle cell anaemia with crisis,Sickle cell trait and disorders,Haemoglobinopathies,Blood,N
2226,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2226,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2226,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2226,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2227,1,Headache,Headaches NEC,Headaches,Nerv,N
2227,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2227,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2227,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2228,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
2228,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2228,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2228,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2229,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,Y
2230,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2231,1,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2231,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2231,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2231,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2231,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
2232,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2232,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2232,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2232,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2233,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2233,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2233,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2233,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2233,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2233,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2233,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2233,8,Myopathy,Myopathies,Muscle disorders,Musc,N
2233,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2234,1,Renal function test abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2234,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2235,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2235,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2236,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2236,2,Skin toxicity,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2236,3,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
2237,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2238,1,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
2239,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2240,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2240,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2240,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
2240,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2240,5,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
2240,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2240,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2240,8,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2240,9,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2241,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2241,2,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2241,3,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2241,4,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2241,5,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2241,6,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2241,7,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2241,8,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
2241,9,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
2241,10,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2241,11,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2241,12,Death,Death and sudden death,Fatal outcomes,Genrl,N
2241,13,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2241,14,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2241,15,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2241,16,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2241,17,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2241,18,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2241,19,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2241,20,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
2241,21,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2241,22,Headache,Headaches NEC,Headaches,Nerv,N
2241,23,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2241,24,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2241,25,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2241,26,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2241,27,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
2241,28,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
2241,29,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2241,30,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2241,31,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2241,32,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2241,33,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2241,34,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2241,35,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2241,36,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2241,37,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2242,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2242,2,Immunoblastic lymphoma,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
2243,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2244,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2245,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2246,1,Immunoblastic lymphoma,Non-Hodgkin's lymphomas unspecified histology aggressive,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2246,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2247,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2247,2,Headache,Headaches NEC,Headaches,Nerv,N
2248,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2248,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2249,1,Intraocular pressure test abnormal,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2249,2,Trabeculectomy,Iris and ciliary body therapeutic procedures,Eye therapeutic procedures,Surg,N
2250,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2250,2,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
2250,3,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
2250,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2251,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
2251,2,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2251,3,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2252,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2252,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2252,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2252,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2253,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2254,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2254,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2254,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2254,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2254,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2254,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2254,7,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2254,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2254,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2254,10,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2254,11,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2254,12,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2254,13,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2254,14,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2254,15,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2254,16,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2255,1,Headache,Headaches NEC,Headaches,Nerv,N
2255,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2255,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2256,1,Headache,Headaches NEC,Headaches,Nerv,N
2256,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2257,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2257,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2257,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2257,4,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2257,5,Sudden hearing loss,Hearing losses,Hearing disorders,Ear,N
2257,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2257,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2258,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2258,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2258,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2259,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2259,2,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2259,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2259,4,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2259,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2259,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2259,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2259,8,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2260,1,CNS ventriculitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2260,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
2260,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2260,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2260,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2260,6,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2260,7,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
2260,8,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2260,9,Migraine,Migraine headaches,Headaches,Nerv,N
2260,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2260,11,Septic cerebral embolism,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2261,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2261,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2261,3,Meningitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2261,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2262,1,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
2262,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2262,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2262,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2262,5,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2263,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2263,2,Diverticulum,Diverticula,Diverticular disorders,Gastr,N
2263,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2264,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
2264,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2265,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2266,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2266,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2266,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2266,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2267,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2268,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2269,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
2269,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
2270,1,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2270,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2270,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2271,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2271,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2272,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2273,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2273,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2273,3,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2273,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2273,5,Thalamic infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2274,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2275,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2276,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2277,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
2277,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2277,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2277,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2278,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2279,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2280,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2280,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2280,3,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2281,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2281,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2282,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2283,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2283,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2283,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2283,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2284,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2285,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2285,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2285,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2285,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2286,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2287,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2287,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2287,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
2288,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2289,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2289,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2290,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2291,1,Trabeculectomy,Iris and ciliary body therapeutic procedures,Eye therapeutic procedures,Surg,N
2292,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2292,2,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2293,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2293,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,Y
2294,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2295,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2295,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2295,3,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
2296,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2297,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2298,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2298,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2298,3,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2298,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2298,5,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2299,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
2299,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2300,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2301,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2302,1,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
2302,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2302,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2302,4,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2302,5,Paradoxical drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2303,1,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
2303,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2304,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2304,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2305,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2305,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2306,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2306,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2306,3,Headache,Headaches NEC,Headaches,Nerv,N
2306,4,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2306,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2307,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2307,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2307,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2307,4,N-terminal prohormone brain natriuretic peptide decreased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
2307,5,N-terminal prohormone brain natriuretic peptide increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
2307,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2307,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2307,8,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2307,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2308,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
2308,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2308,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2308,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2308,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2308,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2308,7,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2309,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
2309,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2310,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2310,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2310,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2311,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2312,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
2312,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2312,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2312,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2312,5,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2312,6,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2313,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2314,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2314,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2314,3,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2314,4,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2315,1,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2315,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2316,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2316,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2316,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2316,4,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2317,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2318,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
2318,2,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,Y
2318,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2318,4,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2319,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2319,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2319,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2320,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2320,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2320,3,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2320,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2320,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2321,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2322,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2322,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
2322,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2322,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2322,5,Vaccination failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2323,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2323,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2323,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2324,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2324,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2325,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2326,1,Microcytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2327,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2328,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2328,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2328,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2328,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2328,5,Product communication issue,Product transcribing errors and communication issues,Medication errors and other product use errors and issues,Inj&P,N
2329,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2330,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2331,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2332,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2332,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
2332,3,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2333,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2333,2,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
2333,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2333,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2333,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2334,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2335,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2336,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
2336,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2336,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2336,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2337,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2337,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2337,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2337,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2337,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2337,6,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2337,7,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2337,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2337,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2337,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2337,11,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2337,12,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2337,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2338,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2339,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2339,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2339,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2339,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2339,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2339,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2340,1,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
2340,2,Infusion site reaction,Infusion site reactions,Administration site reactions,Genrl,N
2340,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2341,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2341,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2341,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2341,4,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2341,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2341,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2341,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2341,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2342,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2342,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2343,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2343,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2343,3,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2343,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2343,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2343,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2343,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2343,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2343,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2343,10,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2343,11,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2343,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2343,13,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2343,14,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2343,15,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2343,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2344,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2345,1,Neuritis,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2345,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2346,1,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2347,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2347,2,Headache,Headaches NEC,Headaches,Nerv,N
2348,1,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2349,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2350,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2350,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2350,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2351,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2351,2,Corneal perforation,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
2351,3,Keratoconus,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
2351,4,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2352,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2352,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2353,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2353,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2354,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2355,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
2355,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2355,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2356,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2357,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2357,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2357,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2358,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2359,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2359,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2360,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2360,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2361,1,Brain neoplasm,Nervous system neoplasms unspecified malignancy NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,Y
2361,2,Glioblastoma,Glial tumours malignant,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
2361,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2362,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2363,1,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
2363,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
2363,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2364,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2365,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2366,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2366,2,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
2366,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2366,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2366,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2367,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2367,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2367,3,Keratoconus,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
2368,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2369,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2370,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
2370,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2370,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2370,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2370,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2370,6,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2370,7,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
2370,8,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2370,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2370,10,Thalamic infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2370,11,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2370,12,Tuberculosis of central nervous system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2370,13,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2371,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2371,2,Corneal disorder,Corneal disorders NEC,Eye disorders NEC,Eye,N
2371,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2371,4,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
2371,5,Flat anterior chamber of eye,"Anterior chamber structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
2371,6,Hypopyon,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2371,7,Intraocular pressure test abnormal,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2371,8,Keratoconus,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
2371,9,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2372,1,Plasma cell myeloma refractory,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2373,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2373,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2374,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2375,1,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2376,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2376,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2377,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2377,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2378,1,Headache,Headaches NEC,Headaches,Nerv,N
2378,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2379,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
2379,2,Facial asymmetry,"Musculoskeletal and connective tissue deformities of skull, face and buccal cavity",Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2379,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2379,4,Gross motor delay,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2379,5,Plagiocephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
2379,6,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2380,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2381,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
2382,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2382,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2383,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2384,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2385,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2385,2,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
2385,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2386,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2386,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2387,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2387,2,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
2387,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2387,4,Nutritional condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2388,1,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2389,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2390,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2390,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2391,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2392,1,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2392,2,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2392,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2392,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2393,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2394,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2395,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2396,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
2396,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2396,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2397,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2397,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2397,3,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2398,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2398,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2399,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2399,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2399,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2400,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2400,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2400,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2401,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2401,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2401,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2401,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2401,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2401,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2401,7,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2402,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
2402,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2402,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2403,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
2403,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2403,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2404,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2404,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2404,3,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2404,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2405,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2406,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
2406,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2406,3,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
2406,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2407,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2407,2,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2408,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2409,1,Procedural nausea,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2410,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2410,2,Pseudomyopia,Refractive and accommodative disorders,Vision disorders,Eye,N
2411,1,Cerebral nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2411,2,Pulmonary nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2412,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2413,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2413,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2414,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2415,1,Intraocular pressure decreased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2416,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2416,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2416,3,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2416,4,Headache,Headaches NEC,Headaches,Nerv,N
2416,5,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
2416,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2416,7,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2416,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2416,9,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2417,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2417,2,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2418,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2419,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2419,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2420,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2420,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2420,3,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2421,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2421,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2422,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2422,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2422,3,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2423,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2424,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2424,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2424,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
2424,4,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2424,5,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2424,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2424,7,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
2425,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2426,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2426,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2427,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2427,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2428,1,Cardiac amyloidosis,Cardiomyopathies,Myocardial disorders,Card,Y
2428,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2428,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2429,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2429,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2430,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2431,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
2431,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2431,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2431,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2431,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2431,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2431,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2432,1,Headache,Headaches NEC,Headaches,Nerv,N
2433,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2433,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2434,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2435,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2436,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2437,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2438,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2438,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2438,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
2438,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2439,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2439,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2439,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2440,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2441,1,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2442,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2442,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2442,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2442,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2442,5,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2443,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2443,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2444,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2444,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2445,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2446,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2446,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2446,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2447,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2447,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2448,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2449,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2449,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2450,1,Scoliosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
2451,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2451,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2452,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
2452,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2452,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2453,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2454,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2455,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2455,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2455,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2455,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2455,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2456,1,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2456,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2457,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2458,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2458,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2458,3,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2459,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2460,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2461,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2461,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2462,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2462,2,Laboratory test interference,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2463,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2463,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2463,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2464,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2464,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2464,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2464,4,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
2464,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2464,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2464,7,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2464,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2465,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2465,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2465,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2466,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2466,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2466,3,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
2466,4,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2466,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2467,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2467,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2467,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2468,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2468,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2468,3,Headache,Headaches NEC,Headaches,Nerv,N
2468,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2468,5,Lip injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2468,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2469,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2469,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2470,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2470,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2471,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2471,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
2471,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2472,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2472,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2473,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2473,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2473,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2473,4,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
2473,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2473,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2474,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2475,1,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
2475,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2476,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2476,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2476,3,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2477,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2477,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2477,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2477,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2477,5,Headache,Headaches NEC,Headaches,Nerv,N
2477,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2477,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2477,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2478,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2479,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2480,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2480,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2481,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
2481,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2482,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2483,1,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2484,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2485,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2485,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2486,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2487,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2487,2,Saliva altered,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2487,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2487,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2488,1,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2489,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2489,2,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2489,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
2489,4,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2489,5,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
2489,6,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2489,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2489,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2490,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2490,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2490,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2490,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2490,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2491,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2491,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2491,3,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
2491,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2491,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2491,6,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2491,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2491,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2491,9,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2491,10,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2491,11,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2491,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2491,13,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2492,1,Acne,Acnes,Skin appendage conditions,Skin,N
2492,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2492,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2492,4,Myopathy,Myopathies,Muscle disorders,Musc,N
2492,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2492,6,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2493,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2493,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2493,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2494,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
2494,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2494,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2494,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2494,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2495,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2495,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2495,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2495,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2495,5,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2495,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2495,7,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2495,8,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2495,9,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2495,10,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2495,11,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2495,12,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2495,13,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2495,14,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2496,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2496,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2496,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2497,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2498,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2499,1,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2500,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2501,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2502,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2503,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2504,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2505,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2506,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2507,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
2508,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2508,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2508,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2508,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2508,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2508,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2509,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2509,2,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2509,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2510,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2510,2,Lip disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2511,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2512,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2512,2,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
2512,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2512,4,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
2512,5,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
2512,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2512,7,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2513,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2513,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2513,3,Optic nerve injury,Cranial nerve injuries,Injuries NEC,Inj&P,N
2513,4,Pupillary reflex impaired,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2513,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2513,6,Visual field defect,Visual field disorders,Vision disorders,Eye,N
2514,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2515,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2515,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2515,3,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2515,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2516,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2516,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2517,1,Acne,Acnes,Skin appendage conditions,Skin,N
2517,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2517,3,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2517,4,Myopathy,Myopathies,Muscle disorders,Musc,N
2517,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2517,6,Skin striae,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2517,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2518,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2518,2,Gastrointestinal stromal tumour,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
2518,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2518,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2518,5,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2518,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2518,7,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
2519,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2519,2,Adrenal mass,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
2519,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2519,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2520,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2521,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
2521,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2521,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2521,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2521,5,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
2521,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2521,7,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2521,8,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
2521,9,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
2521,10,Palate injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
2522,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2522,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2522,3,Fibrin deposition on lens postoperative,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2523,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2523,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2524,1,Complication of device insertion,Complications associated with device NEC,Complications associated with device,Genrl,N
2524,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2525,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2525,2,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2525,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2525,4,Ulcerative keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2526,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2526,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2526,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2526,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
2527,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2527,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2528,1,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2529,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2530,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2530,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2530,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
2531,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2531,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2532,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2532,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2532,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2533,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
2534,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2535,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2535,2,Headache,Headaches NEC,Headaches,Nerv,N
2535,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2535,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2536,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2536,2,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2536,3,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
2536,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2536,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2536,6,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2536,7,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2536,8,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2536,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2537,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2537,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2538,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2539,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2539,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2540,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2541,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2542,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2542,2,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2543,1,Conjunctival disorder,"Conjunctival structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
2543,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2543,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2543,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2543,5,Intraocular pressure test abnormal,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2543,6,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2543,7,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
2543,8,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2544,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2545,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2546,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2547,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2547,2,Vulvovaginal pruritus,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2548,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2549,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2549,2,External ear pain,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
2550,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2550,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2550,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2550,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2550,5,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2551,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2551,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2551,3,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2552,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2552,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2552,3,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2552,4,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2552,5,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2552,6,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2552,7,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2552,8,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2552,9,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2552,10,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2552,11,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2552,12,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2552,13,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2552,14,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2552,15,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2552,16,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2552,17,Genital pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
2552,18,Genital ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
2552,19,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2552,20,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2552,21,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
2552,22,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2552,23,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2552,24,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,Y
2552,25,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2552,26,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2552,27,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2552,28,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
2552,29,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2552,30,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2552,31,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2552,32,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2552,33,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2552,34,Pulmonary pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2552,35,Radiation inflammation,Radiation injuries,Injuries by physical agents,Inj&P,N
2552,36,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2552,37,Schizophrenia,Schizophrenia NEC,Schizophrenia and other psychotic disorders,Psych,N
2552,38,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2553,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2554,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2554,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2554,3,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2555,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2556,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2557,1,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2557,2,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2557,3,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2557,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2558,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2559,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2559,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2559,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2560,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2561,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2562,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2563,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2563,2,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2563,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2564,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2564,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2564,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2565,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2565,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2565,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2566,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2567,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2568,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2568,2,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2569,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2570,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2570,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2571,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2571,2,Pseudo Cushing's syndrome,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2571,3,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2572,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2572,2,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2573,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2573,2,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2573,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2574,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2574,2,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2575,1,Vulvovaginal burning sensation,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2576,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2576,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2577,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2577,2,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2577,3,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2577,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2578,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2578,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2578,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2578,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2579,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2579,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2579,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2579,4,Sensitisation,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2579,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2579,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2580,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2580,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2580,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2580,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2581,1,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2581,2,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2581,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2581,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2581,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2581,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2582,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2582,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2583,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2583,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2583,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2583,4,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2584,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2584,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2584,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2584,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2585,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2585,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2586,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2586,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2586,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2586,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2587,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2588,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2589,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2590,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2590,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2591,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2591,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2591,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2591,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2591,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2591,6,Death,Death and sudden death,Fatal outcomes,Genrl,N
2591,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2591,8,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2591,9,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2591,10,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2591,11,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2591,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2591,13,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2591,14,Headache,Headaches NEC,Headaches,Nerv,N
2591,15,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2591,16,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2591,17,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2591,18,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2591,19,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2591,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2591,21,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2591,22,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2591,23,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2591,24,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2591,25,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2591,26,Skin candida,Candida infections,Fungal infectious disorders,Infec,N
2591,27,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2592,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2593,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
2594,1,Haematotoxicity,Haematological disorders,Haematological disorders NEC,Blood,N
2595,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2596,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
2596,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2597,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2598,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2599,1,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2599,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2599,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2600,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2601,1,Conjunctival laceration,Eye injuries NEC,Injuries NEC,Inj&P,N
2601,2,Implantation complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2601,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2602,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2602,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2603,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
2603,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2604,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2604,2,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2604,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2604,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2605,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2605,2,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
2605,3,Device dislocation,Device issues NEC,Device issues,Prod,N
2605,4,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2605,5,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2605,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2606,1,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2606,2,Ocular discomfort,Ocular disorders NEC,Eye disorders NEC,Eye,N
2606,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2607,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2607,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2607,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2608,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2608,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2609,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2609,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2609,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2610,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2611,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2611,2,Stress cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
2612,1,Intra-ocular injection complication,Eye and ear procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2612,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2613,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2614,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2615,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2616,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2617,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2617,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2618,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2619,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2619,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2619,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2620,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2620,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2621,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2622,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2622,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
2623,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2624,1,Genital infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2624,2,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2624,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
2624,4,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2624,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2624,6,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2624,7,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2624,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2624,9,Vulval abscess,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
2625,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2625,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2625,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2625,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2626,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
2626,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2626,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2626,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2626,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2626,6,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2626,7,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2626,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2626,9,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2626,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2626,11,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2626,12,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2626,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2626,14,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2626,15,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2626,16,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2626,17,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2626,18,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2627,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2628,1,Pupil dilation procedure,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2629,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2629,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2629,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2630,1,Red blood cell agglutination,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
2631,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2632,1,Migraine,Migraine headaches,Headaches,Nerv,N
2632,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2633,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2633,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2634,1,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
2635,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2636,1,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2637,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2637,2,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2637,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2637,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2637,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2637,6,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2637,7,"Sleep disorder due to general medical condition, insomnia type",Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2637,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2638,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2639,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2640,1,Bloody discharge,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2641,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2641,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2641,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2642,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2642,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2643,1,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2643,2,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
2644,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2644,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2644,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2645,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2645,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2645,3,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2645,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2645,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2645,6,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
2645,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2645,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2645,9,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2645,10,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2645,11,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
2645,12,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2645,13,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2645,14,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2645,15,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2645,16,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2645,17,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
2645,18,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2646,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2646,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
2646,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2647,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2648,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2648,2,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
2649,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2650,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2650,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2651,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2651,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2651,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2651,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2651,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2652,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2653,1,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
2654,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2655,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
2655,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2655,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2655,4,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2655,5,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2655,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2655,7,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2655,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2655,9,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2655,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2655,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2655,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2655,13,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2655,14,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2655,15,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2655,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2656,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2656,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2656,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2656,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2656,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2657,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2657,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2657,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2657,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2657,5,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2657,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2657,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2658,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2659,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2660,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2660,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2660,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2660,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2660,5,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2661,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2661,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2661,3,Oral infection,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
2661,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2662,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2662,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2663,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
2663,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
2664,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2664,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2664,3,Human herpesvirus 6 encephalitis,Herpes viral infections,Viral infectious disorders,Infec,N
2664,4,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
2665,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2665,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2665,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2665,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2665,5,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2665,6,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2665,7,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2665,8,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2666,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2666,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2666,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2667,1,Nail ridging,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2667,2,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
2667,3,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2668,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2668,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2669,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2670,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2670,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2670,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2671,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2671,2,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
2671,3,Tympanic membrane perforation,Tympanic membrane disorders (excl infections),Middle ear disorders (excl congenital),Ear,N
2672,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2672,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2672,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2673,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2673,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
2673,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2673,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2674,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2674,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2674,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2674,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2674,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2675,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2675,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2675,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2675,4,Oesophageal disorder,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2675,5,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2675,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2676,1,Plasma cell myeloma recurrent,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2677,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2677,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2677,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2678,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2678,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2678,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2679,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2680,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2681,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2682,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2682,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2682,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2682,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2682,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2682,6,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
2682,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2683,1,Intraocular pressure test abnormal,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2684,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2684,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
2684,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2684,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2684,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2684,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2684,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2684,8,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2685,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2685,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2686,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2687,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2688,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2689,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2690,1,Hypotony of eye,Ocular disorders NEC,Eye disorders NEC,Eye,N
2691,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2692,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2692,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2693,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2693,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2694,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2694,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2695,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2695,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2696,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2697,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2697,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2698,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2698,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2699,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2700,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2700,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2700,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2701,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2702,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2703,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2703,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2704,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2704,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2705,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2705,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2705,3,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2705,4,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2705,5,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
2705,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2705,7,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2705,8,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2706,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2707,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2707,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2707,3,Pulmonary nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,Y
2708,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2709,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2709,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2709,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2709,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2709,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2709,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2709,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2710,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2710,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2710,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2710,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2710,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2711,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2711,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2711,3,Lymphocyte count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2711,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2711,5,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2712,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,Y
2712,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2712,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2712,4,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
2712,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2712,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2712,7,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2713,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2713,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
2713,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2713,4,Terminal insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2714,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2715,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2715,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2716,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2717,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2718,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2719,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2720,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2720,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2721,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2722,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2723,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2723,2,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2724,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2724,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2724,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2725,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2726,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2727,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2727,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2727,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2728,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
2728,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2728,3,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
2728,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2728,5,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2728,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2728,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2729,1,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2729,2,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2730,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2731,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2731,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
2732,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2733,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2734,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
2735,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2736,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2736,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2736,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2737,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
2738,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2739,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2740,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2740,2,Retinal vasculitis,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
2741,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2741,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
2741,3,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2741,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2741,5,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2741,6,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2741,7,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
2741,8,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2741,9,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2741,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2741,11,Pancreatic neuroendocrine tumour,Islet cell neoplasms and APUDoma NEC,Endocrine neoplasms malignant and unspecified,Neopl,N
2741,12,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2741,13,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2741,14,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2742,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2742,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2743,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2743,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2743,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2744,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2745,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2745,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2746,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2747,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2747,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2747,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2748,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2748,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2749,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2749,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2750,1,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
2750,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2750,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2750,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2751,1,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
2752,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2752,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2753,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
2753,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2754,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2755,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2756,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2756,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2757,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2757,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2758,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2759,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2759,2,Eye oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
2759,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2760,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2761,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2762,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2763,1,Headache,Headaches NEC,Headaches,Nerv,N
2764,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2765,1,Aspiration bone marrow,Bone marrow and immune tissue histopathology procedures,Haematology investigations (incl blood groups),Inv,N
2765,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2765,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2765,4,Osteolysis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
2766,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2767,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2767,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2767,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2767,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2767,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2768,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2768,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2769,1,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
2769,2,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
2769,3,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
2770,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2770,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2770,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2771,1,Cataract subcapsular,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2771,2,Keratoconus,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
2772,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
2773,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2773,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2774,1,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2775,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2776,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2778,1,Adjusted calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2778,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
2779,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2779,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2779,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2779,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2780,1,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2781,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2782,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2783,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2783,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2784,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2785,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
2785,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2786,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2786,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2787,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2788,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2788,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2789,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2789,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2790,1,Headache,Headaches NEC,Headaches,Nerv,N
2791,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2791,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2792,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2792,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2793,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2793,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2794,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2794,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2795,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2796,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2796,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2796,3,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2796,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2796,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2796,6,Headache,Headaches NEC,Headaches,Nerv,N
2796,7,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2796,8,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
2796,9,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
2796,10,Hypofibrinogenaemia,Coagulation factor deficiencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2796,11,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2796,12,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2796,13,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2796,14,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2796,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2796,16,Retroperitoneal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2797,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2797,2,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
2797,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2798,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2799,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2799,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2799,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2799,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2800,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2801,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2802,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2803,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2804,1,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
2805,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2806,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2806,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
2806,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2806,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2807,1,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
2807,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2808,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2809,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2809,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2810,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2810,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2811,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2811,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2812,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
2812,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2813,1,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
2814,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2814,2,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2815,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2816,1,Ocular hypertension,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
2817,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2817,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2817,3,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2817,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2817,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2817,6,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2817,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2818,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2818,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
2819,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2820,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2820,2,Deafness,Hearing losses,Hearing disorders,Ear,N
2820,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2820,4,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2820,5,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2820,6,Headache,Headaches NEC,Headaches,Nerv,N
2821,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2822,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2822,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2822,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2823,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
2824,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2825,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2826,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2827,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2828,1,Vulvovaginal discomfort,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
2829,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2830,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2831,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
2832,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2832,2,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
2832,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2833,1,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2834,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
2835,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2836,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2837,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2838,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2839,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2840,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2840,2,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2841,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
2842,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2843,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2843,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2843,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2844,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2844,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
2845,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2846,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2847,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2847,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2848,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2848,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2849,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2850,1,Madarosis,Alopecias,Skin appendage conditions,Skin,N
2851,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2852,1,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
2852,2,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2853,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2854,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2854,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2854,3,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2854,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2854,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2855,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
2855,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2856,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
2857,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2858,1,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
2859,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
2859,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
2860,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
2860,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2861,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2862,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2863,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2864,1,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2864,2,Muscle strength abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2864,3,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2864,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2864,5,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
2865,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2865,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2866,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2867,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2867,2,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
2867,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2867,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2868,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2869,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2870,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2870,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2871,1,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2872,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2873,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2874,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2875,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2875,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2876,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2876,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2877,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2877,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
2877,3,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2878,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2879,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2879,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2879,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2880,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2881,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2882,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2883,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2883,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2883,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2884,1,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2885,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
2886,1,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2886,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2887,1,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2887,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2888,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2888,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2889,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2889,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2890,1,Neurodevelopmental disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2890,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2891,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
2891,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2891,3,Energy increased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2891,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2891,5,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
2891,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2891,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2891,8,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2891,9,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2891,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2892,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2893,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2894,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2895,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2896,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
2897,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
2897,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2898,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2899,1,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
2899,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
2899,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2899,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2900,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
2901,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
2902,1,Vitreoretinal traction syndrome,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2902,2,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2903,1,Intraocular pressure test,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
2904,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2905,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2906,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2906,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2907,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2907,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2908,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2908,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2909,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2909,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2910,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2910,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2911,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2911,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2912,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2912,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2913,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2913,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2914,1,Brain empyema,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2914,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2915,1,Brain empyema,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2915,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2916,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2916,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2917,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2917,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2918,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2918,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2919,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2919,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2920,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
2920,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2921,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2921,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2921,3,Senile dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2922,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2922,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2922,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2923,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2923,2,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2923,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2924,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2924,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2925,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
2925,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2926,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2926,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2927,1,Brain empyema,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2927,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2927,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2927,4,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
2928,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
2928,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2929,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
2929,2,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2930,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2930,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,Y
2930,3,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2931,1,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2931,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2931,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2932,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
2933,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
2933,2,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2933,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2933,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2934,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2934,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
2934,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2934,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2934,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2934,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2935,1,Bacillus infection,Bacillary infections,Bacterial infectious disorders,Infec,N
2935,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2935,3,Pulmonary nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,Y
2936,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2936,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2937,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2937,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2938,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2939,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2939,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2940,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2940,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2941,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2941,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2942,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2942,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2943,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2943,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2944,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2944,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2945,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2945,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2946,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2946,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2947,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2947,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2948,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2948,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
2949,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2949,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2950,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2950,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2951,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2951,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2952,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2952,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2953,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2953,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2954,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2954,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2955,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2955,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2956,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2956,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2956,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2957,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2957,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2958,1,Gastrointestinal tract irritation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2958,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2959,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2959,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2960,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2960,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2961,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2961,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2962,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2962,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2963,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,Y
2963,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2964,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2965,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2966,1,Eyelid oedema,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2966,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2967,1,Vitreous haemorrhage,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
2968,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2968,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2969,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2969,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2970,1,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
2971,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2971,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2971,3,Horner's syndrome,Autonomic nervous system disorders,Neuromuscular disorders,Nerv,N
